1. DiehlAK. Epidemiology and natural history of gallstone disease. Gastroenterol Clin North Am1991;20:1.

2. SherlockS, DooleyJ. Diseases of the Liver and Biliary System. Oxford: Blackwell Science; 2002: 597.

3. TrotmanBW, OstrowJD, SolowayRD. Pigment vs cholesterol cholelithiasis: comparison of stone type and bile composition. Am J Dig Dis1974;19:585. CrossRef

4. AttiliAF, CarulliN, RodaE, et al. Epidemiology of gallstone disease in Italy: prevalence data of the multicenter italian study on cholelithiasis (M.I.COL.). Am J Epidemiol1995;141:158.

5. PortincasaP, MoschettaA, PalascianoG. Cholesterol gallstone disease. Lancet2006;368:230. CrossRef

6. WangDQ, AfdhalNH. Genetic analysis of cholesterol gallstone formation: searching for Lith (gallstone) genes. Curr Gastroenterol Rep2004;6:140. CrossRef

7. EverhartJE, KhareM, HillM, et al. Prevalence and ethnic differences in gallbladder disease in the United States. Gastroenterology1999;117:632. CrossRef

8. SandlerRS, EverhartJE, DonowitzM, et al. The burden of selected digestive diseases in the United States. Gastroenterology2002;122:1500. CrossRef

9. Liver Disease Subcommittee of the Digestive Disease Interagency Coordinating Committee. Action Plan for Liver Disease Research. Bethesda, MD: NIH; 2004: 145.

10. EverhartJE, RuhlCE. Burden of digestive diseases in the United States Part III: liver, biliary tract, and pancreas. Gastroenterology2009;136:1134. CrossRef

11. ShafferEA. Epidemiology and risk factors for gallstone disease: has the paradigm changed in the 21st century?Curr Gastroenterol Rep2005;7:132. CrossRef

12. National Institutes of Health Consensus Development Conference Statement on G, Laparoscopic C. Am J Surg1993;165:390. CrossRef

13. StintonLM, MyersRP, ShafferEA. Epidemiology of gallstones. Gastroenterol Clin North Am2010;39:157. CrossRef

14. GrundySM, BarnettJP. Metabolic and health complications of obesity. Dis Mon1990;36:641.

15. GrundySM. Metabolic syndrome scientific statement by the American Heart Association and the National Heart, Lung, and Blood Institute. Arterioscler Thromb Vasc Biol2005;25:2243. CrossRef

16. GrundySM, CleemanJI, DanielsSR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation2005;112:2735. CrossRef

17. EckelRH, GrundySM, ZimmetPZ. The metabolic syndrome. Lancet2005;365:1415. CrossRef

18. TsaiCJ, LeitzmannMF, WillettWC, et al. Prospective study of abdominal adiposity and gallstone disease in US men. Am J Clin Nutr2004;80:38.

19. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III).Circulation2002;106:3143.

20. SamplinerRE, BennettPH, ComessLJ, et al. Gallbladder disease in Pima indians. Demonstration of high prevalence and early onset by cholecystography. N Engl J Med1970;283:1358. CrossRef

21. EverhartJE, YehF, LeeET, et al. Prevalence of gallbladder disease in American Indian populations: findings from the Strong Heart Study. Hepatology2002;35:1507. CrossRef

22. MiquelJF, CovarrubiasC, VillaroelL, et al. Genetic epidemiology of cholesterol cholelithiasis among Chilean Hispanics, Amerindians, and Maoris. Gastroenterology1998;115:937. CrossRef

23. NewmanHF, NorthupJD. The autopsy incidence of gallstones. Surg Gynecol Obstet1959;109:1.

24. CunninghamJA, HardenberghFE. Comparative incidence of choletithiasis in the Negro and white races; a study of 6185 autopsies. AMA Arch Intern Med1956;97:68. CrossRef

25. NomuraH, KashiwagiS, HayashiJ, et al. Prevalence of gallstone disease in a general population of Okinawa, Japan. Am J Epidemiol1988;128:598.

26. GilatT, FeldmanC, HalpernZ, et al. An increased familial frequency of gallstones. Gastroenterology1983;84:242.

27. SarinSK, NegiVS, DewanR, et al. High familial prevalence of gallstones in the first‐degree relatives of gallstone patients. Hepatology1995;22:138.

28. RosmorducO, HermelinB, BoellePY, et al. ABCB4 gene mutation‐associated cholelithiasis in adults. Gastroenterology2003;125:452. CrossRef

29. RosmorducO, PouponR. Low phospholipid associated cholelithiasis: association with mutation in the MDR3/ABCB4 gene. Orphanet J Rare Dis2007;2:29. CrossRef

30. BuchS, SchafmayerC, VolzkeH, et al. A genome‐wide association scan identifies the hepatic cholesterol transporter ABCG8 as a susceptibility factor for human gallstone disease. Nat Genet2007;39:995. CrossRef

31. BuchS, SchafmayerC, VolzkeH, et al. Loci from a genome‐wide analysis of bilirubin levels are associated with gallstone risk and composition. Gastroenterology2010;139:1942. CrossRef

32. CareyMC, SmallDM. The physical chemistry of cholesterol solubility in bile. Relationship to gallstone formation and dissolution in man. J Clin Invest1978;61:998. CrossRef

33. HofmannAF. Bile acids: trying to understand their chemistry and biology with the hope of helping patients. Hepatology2009;49:1403. CrossRef

34. OlszewskiMF, HolzbachRT, SaupeA, et al. Liquid crystals in human bile. Nature1973;242:336. CrossRef

35. HofmannAF. The enterohepatic circulation of bile acids in mammals: form and functions. Front Biosci2009;14:2584. CrossRef

36. HolzbachRT, MarshM, OlszewskiM, et al. Cholesterol solubility in bile. Evidence that supersaturated bile is frequent in healthy man. J Clin Invest1973;52:1467. CrossRef

37. HolzbachRT. Metastability behavior of supersaturated bile. Hepatology1984;4:155S. CrossRef

38. GantzDL, WangDQH, CareyMC, et al. Cryoelectron microscopy of a nucleating model bile in vitreous ice: formation of primordial vesicles. Biophys J1999;76:1436. CrossRef

39. CareyMC, MazerNA. Biliary lipid secretion in health and in cholesterol gallstone disease. Hepatology1984;4:31S. CrossRef

40. MazerNA, SchurtenbergP, CareyMC, et al. Quasi‐elastic light scattering studies of native hepatic bile from the dog: comparison with aggregative behavior of model biliary lipid systems. Biochemistry1984;23:1994. CrossRef

41. SomjenGJ, MarikovskyY, LelkesP, et al. Cholesterol‐phospholipid vesicles in human bile: an ultrastructural study. Biochim Biophys Acta1986;879:14. CrossRef

42. SomjenGJ, GilatT. A non‐micellar mode of cholesterol transport in human bile. FEBS Lett1983;156:265. CrossRef

43. WangDQH, Neuschwander‐TetriBA, PortincasaP. The biliary system colloquium series on integrated systems physiology: From molecule to function. Princeton, NJ: Morgan & Claypool Life Sciences; 2012:1.

44. RobinsSJ, FasuloJM. High density lipoproteins, but not other lipoproteins, provide a vehicle for sterol transport to bile. J Clin Invest1997;99:380. CrossRef

45. SchwartzCC, HalloranLG, VlahcevicZR, et al. Preferential utilization of free cholesterol from high‐density lipoproteins for biliary cholesterol secretion in man. Science1978;200:62. CrossRef

46. KozarskyKF, DonaheeMH, RigottiA, et al. Overexpression of the HDL receptor SR‐BI alters plasma HDL and bile cholesterol levels. Nature1997;387:414. CrossRef

47. JiY, WangN, RamakrishnanR, et al. Hepatic scavenger receptor BI promotes rapid clearance of high density lipoprotein free cholesterol and its transport into bile. J Biol Chem1999;274:33398. CrossRef

48. MardonesP, QuinonesV, AmigoL, et al. Hepatic cholesterol and bile acid metabolism and intestinal cholesterol absorption in scavenger receptor class B type I‐deficient mice. J Lipid Res2001;42:170.

49. WangDQ, CareyMC. Susceptibility to murine cholesterol gallstone formation is not affected by partial disruption of the HDL receptor SR‐BI. Biochim Biophys Acta2002;1583:141. CrossRef

50. WangDQ, LeeSP. Physical chemistry of intestinal absorption of biliary cholesterol in mice. Hepatology2008;48:177. CrossRef

51. RobinsSJ, BrunengraberH. Origin of biliary cholesterol and lecithin in the rat: contribution of new synthesis and preformed hepatic stores. J Lipid Res1982;23:604.

52. TurleySD, DietschyJM. Regulation of biliary cholesterol output in the rat: dissociation from the rate of hepatic cholesterol synthesis, the size of the hepatic cholesteryl ester pool, and the hepatic uptake of chylomicron cholesterol. J Lipid Res1979;20:923.

53. SchwartzCC, BermanM, VlahcevicZR, et al. Multicompartmental analysis of cholesterol metabolism in man. Characterization of the hepatic bile acid and biliary cholesterol precursor sites. J Clin Invest1978;61:408. CrossRef

54. WangDQ, ZhangL, WangHH. High cholesterol absorption efficiency and rapid biliary secretion of chylomicron remnant cholesterol enhance cholelithogenesis in gallstone‐susceptible mice. Biochim Biophys Acta2005;1733:90. CrossRef

55. WangDQ, LammertF, PaigenB, et al. Phenotypic characterization of Lith genes that determine susceptibility to cholesterol cholelithiasis in inbred mice: pathophysiology of biliary lipid secretion. J Lipid Res1999;40:2066.

56. CohenDE, CareyMC. Physical chemistry of biliary lipids during bile formation. Hepatology1990;12:143S.

57. CohenDE, LeightonLS, CareyMC. Bile salt hydrophobicity controls vesicle secretion rates and transformations in native bile. Am J Physiol1992;263:G386.

58. CrawfordJM, MockelGM, CrawfordAR, et al. Imaging biliary lipid secretion in the rat: ultrastructural evidence for vesiculation of the hepatocyte canalicular membrane. J Lipid Res1995;36:2147.

59. SmitJJ, SchinkelAH, Oude ElferinkRP, et al. Homozygous disruption of the murine mdr2 P‐glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease. Cell1993;75:451. CrossRef

60. CrawfordAR, SmithAJ, HatchVC, et al. Hepatic secretion of phospholipid vesicles in the mouse critically depends on mdr2 or MDR3 P‐glycoprotein expression. Visualization by electron microscopy. J Clin Invest1997;100:2562. CrossRef

61. DegiorgioD, ColomboC, SeiaM, et al. Molecular characterization and structural implications of 25 new ABCB4 mutations in progressive familial intrahepatic cholestasis type 3 (PFIC3). Eur J Hum Genet2007;15:1230. CrossRef

62. GerloffT, StiegerB, HagenbuchB, et al. The sister of P‐glycoprotein represents the canalicular bile salt export pump of mammalian liver. J Biol Chem1998;273:10046. CrossRef

63. WangR, SalemM, YousefIM, et al. Targeted inactivation of sister of P‐glycoprotein gene (spgp) in mice results in nonprogressive but persistent intrahepatic cholestasis. Proc Natl Acad Sci U S A2001;98:2011. CrossRef

64. WangR, LamP, LiuL, et al. Severe cholestasis induced by cholic acid feeding in knockout mice of sister of P‐glycoprotein. Hepatology2003;38:1489. CrossRef

65. StrautnieksSS, BullLN, KniselyAS, et al. A gene encoding a liver‐specific ABC transporter is mutated in progressive familial intrahepatic cholestasis. Nat Genet1998;20:233. CrossRef

66. LeeMH, LuK, HazardS, et al. Identification of a gene, ABCG5, important in the regulation of dietary cholesterol absorption. Nat Genet2001;27:79.

67. LuK, LeeMH, HazardS, et al. Two genes that map to the STSL locus cause sitosterolemia: genomic structure and spectrum of mutations involving sterolin‐1 and sterolin‐2, encoded by ABCG5 and ABCG8, respectively. Am J Hum Genet2001;69:278. CrossRef

68. LuK, LeeMH, YuH, et al. Molecular cloning, genomic organization, genetic variations, and characterization of murine sterolin genes Abcg5 and Abcg8. J Lipid Res2002;43:565.

69. GrafGA, YuL, LiWP, et al. ABCG5 and ABCG8 are obligate heterodimers for protein trafficking and biliary cholesterol excretion. J Biol Chem2003;278:48275. CrossRef

70. SalenG, PatelS, BattaAK. Sitosterolemia. Cardiovasc Drug Rev2002;20:255. CrossRef

71. LeeMH, LuK, PatelSB. Genetic basis of sitosterolemia. Curr Opin Lipidol2001;12:141. CrossRef

72. YuL, HammerRE, Li‐HawkinsJ, et al. Disruption of Abcg5 and Abcg8 in mice reveals their crucial role in biliary cholesterol secretion. Proc Natl Acad Sci U S A2002;99:16237. CrossRef

73. WangHH, PatelSB, CareyMC, et al. Quantifying anomalous intestinal sterol uptake, lymphatic transport, and biliary secretion in Abcg8(‐/‐) mice. Hepatology2007;45:998. CrossRef

74. KostersA, KunneC, LooijeN, et al. The mechanism of ABCG5/ABCG8 in biliary cholesterol secretion in mice. J Lipid Res2006;47:1959. CrossRef

75. TemelRE, TangW, MaY, et al. Hepatic Niemann‐Pick C1‐like 1 regulates biliary cholesterol concentration and is a target of ezetimibe. J Clin Invest2007;117:1968. CrossRef

76. DevgunMS, El‐NujumiAM, O'DowdGJ, et al. Novel mutations in the Dubin‐Johnson syndrome gene ABCC2/MRP2 and associated biochemical changes. Ann Clin Biochem2012;49:609. CrossRef

77. WangDQ, CohenDE, CareyMC. Biliary lipids and cholesterol gallstone disease. J Lipid Res2009;50(Suppl):S406. CrossRef

78. WangHH, PortincasaP, AfdhalNH, et al. Lith genes and genetic analysis of cholesterol gallstone formation. Gastroenterol Clin North Am2010;39:185. CrossRef

79. WangHH, PortincasaP, WangDQ. Molecular pathophysiology and physical chemistry of cholesterol gallstones. Front Biosci2008;13:401. CrossRef

80. HolanKR, HolzbachRT, HermannRE, et al. Nucleation time: a key factor in the pathogenesis of cholesterol gallstone disease. Gastroenterology1979;77:611.

81. WangDQH, CareyMC. Complete mapping of crystallization pathways during cholesterol precipitation from model bile: influence of physical‐chemical variables of pathophysiologic relevance and identification of a stable liquid crystalline state in cold, dilute and hydrophilic bile salt‐containing system. J Lipid Res1996;37:606.

82. WangDQ, CareyMC. Characterization of crystallization pathways during cholesterol precipitation from human gallbladder biles: identical pathways to corresponding model biles with three predominating sequences. J Lipid Res1996;37:2539.

83. WangDQH, PaigenB, CareyMC. Phenotypic characterization of Lith genes that determine susceptibility to cholesterol cholelithiasis in inbred mice: physical‐chemistry of gallbladder bile. J Lipid Res1997;38:1395.

84. KonikoffFM, ChungDS, DonovanJM, et al. Filamentous, helical, and tubular microstructures during cholesterol crystallization from bile. Evidence that cholesterol does not nucleate classic monohydrate plates. J Clin Invest1992;90:1155. CrossRef

85. KonikoffFM, CohenDE, CareyMC. Phospholipid molecular species influence crystal habits and transition sequences of metastable intermediates during cholesterol crystallization from bile salt‐rich model bile. J Lipid Res1994;35:60.

86. HalpernZ, DudleyMA, KibeA, et al. Rapid vesicle formation and aggregation in abnormal human biles: a time‐lapse video‐enhanced contrast microscopy study. Gastroenterology1986;90:875.

87. HalpernZ, DudleyMA, LynnMP, et al. Vesicle aggregation in model systems of supersaturated bile: relation to crystal nucleation and lipid composition of the vesicular phase. J Lipid Res1986;27:295.

88. HolzbachRT, BuschN. Nucleation and growth of cholesterol crystals. Kinetic determinants in supersaturated native bile. Gastroenterol Clin North Am1991;20:67.

89. HolzbachRT. Cholesterol nucleation in bile. Ital J Gastroenterol Hepatol1995;27:101.

90. HolzbachRT. Current concepts of cholesterol transport and crystal formation in human bile. Hepatology1990;12:26S. CrossRef

91. HolzbachRT, CorbusierC. Liquid crystals and cholesterol nucleation during equilibration in supersaturated bile analogs. Biochim Biophys Acta1978;528:436. CrossRef

92. MazerNA, CareyMC. Quasi‐elastic light‐scattering studies of aqueous biliary lipid systems. Cholesterol solubilization and precipitation in model bile solutions. Biochemistry1983;22:426. CrossRef

93. MazerNA, CareyMC, KwasnickRF, et al. Quasielastic light scattering studies of aqueous biliary lipid systems. Size, shape, and thermodynamics of bile salt micelles. Biochemistry1979;18:3064. CrossRef

94. MazerNA, BenedekGB, CareyMC. Quasielastic light‐scattering studies of aqueous biliary lipid systems. Mixed micelle formation in bile salt‐lecithin solutions. Biochemistry1980;19:601. CrossRef

95. BuschN, HolzbachRT. Crystal growth‐inhibiting proteins in bile. Hepatology1990;12:195S.

96. BuschN, MatiuckN, SahlinS, et al. Inhibition and promotion of cholesterol crystallization by protein fractions from normal human gallbladder bile. J Lipid Res1991;32:695.

97. HolzbachRT. Factors influencing cholesterol nucleation in bile. Hepatology1984;4:173S. CrossRef

98. LeeSP, LaMontJT, CareyMC. Role of gallbladder mucus hypersecretion in the evolution of cholesterol gallstones. J Clin Invest1981;67:1712. CrossRef

99. WomackNA. The development of gallstones. Surg Gynecol Obstet1971;133:937.

100. CareyMC, CahalaneMJ. Whither biliary sludge?Gastroenterology1988;95:508.

101. GendlerSJ, SpicerAP. Epithelial mucin genes. Annu Rev Physiol1995;57:607. CrossRef

102. KimYS, GumJRJr. Diversity of mucin genes, structure, function, and expression. Gastroenterology1995;109:999. CrossRef

103. HoSB, NiehansGA, LyftogtC, et al. Heterogeneity of mucin gene expression in normal and neoplastic tissues. Cancer Res1993;53:641.

104. VermaM, DavidsonEA. Mucin genes: structure, expression and regulation. Glycoconj J1994;11:172. CrossRef

105. WangHH, AfdhalNH, GendlerSJ, et al. Evidence that gallbladder epithelial mucin enhances cholesterol cholelithogenesis in MUC1 transgenic mice. Gastroenterology2006;131:210. CrossRef

106. WangHH, AfdhalNH, GendlerSJ, et al. Targeted disruption of the murine mucin gene 1 decreases susceptibility to cholesterol gallstone formation. J Lipid Res2004;45:438. CrossRef

107. KibeA, HolzbachRT, LaRussoNF, et al. Inhibition of cholesterol crystal formation by apolipoproteins in supersaturated model bile. Science1984;225:514. CrossRef

108. HolzbachRT, KibeA, ThielE, et al. Biliary proteins. Unique inhibitors of cholesterol crystal nucleation in human gallbladder bile. J Clin Invest1984;73:35. CrossRef

109. SecknusR, DarbyGH, ChernoskyA, et al. Apolipoprotein A‐I in bile inhibits cholesterol crystallization and modifies transcellular lipid transfer through cultured human gall‐bladder epithelial cells. J Gastroenterol Hepatol1999;14:446. CrossRef

110. PortincasaP, Di CiaulaA, WangHH, et al. Coordinate regulation of gallbladder motor function in the gut‐liver axis. Hepatology2008;47:2112. CrossRef

111. PortincasaP, Di CiaulaA, vanBerge‐HenegouwenGP. Smooth muscle function and dysfunction in gallbladder disease. Curr Gastroenterol Rep2004;6:151. CrossRef

112. ConterRL, RoslynJJ, Porter‐FinkV, et al. Gallbladder absorption increases during early cholesterol gallstone formation. Am J Surg1986;151:184. CrossRef

113. RoslynJJ, DotyJ, PittHA, et al. Enhanced gallbladder absorption during gallstone formation: the roles of cholesterol saturated bile and gallbladder stasis. Am J Med Sci1986;292:75. CrossRef

114. Ginanni CorradiniS, EliseiW, GiovannelliL, et al. Impaired human gallbladder lipid absorption in cholesterol gallstone disease and its effect on cholesterol solubility in bile. Gastroenterology2000;118:912. CrossRef

115. YuP, ChenQ, BiancaniP, et al. Membrane cholesterol alters gallbladder muscle contractility in prairie dogs. Am J Physiol1996;271:G56.

116. HuangYC, ZhangXW, YangRX. Changes in cholelithiasis in Tianjin in the past 30 years. Chin Med J (Engl)1984;97:133.

117. HuangZQ. Characteristic features of cholelithiasis in China. A nationwide survey of 11342 surgical cases 1983‐1985. Zhonghua Wai Ke Za Zhi1987;25:321.

118. ZhuX, ZhangS, HuangZ. [The trend of the gallstone disease in China over the past decade]. Zhonghua Wai Ke Za Zhi1995;33:652.

119. NakayamaF, MiyakeH. Changing state of gallstone disease in Japan. Composition of the stones and treatment of the condition. Am J Surg1970;120:794. CrossRef

120. NagaseM, TanimuraH, SetoyamaM, et al. Present features of gallstones in Japan. A collective review of 2,144 cases. Am J Surg1978;135:788. CrossRef

121. WangDQ, SchmitzF, KopinAS, et al. Targeted disruption of the murine cholecystokinin‐1 receptor promotes intestinal cholesterol absorption and susceptibility to cholesterol cholelithiasis. J Clin Invest2004;114:521. CrossRef

122. DowlingRH, VeyseyMJ, PereiraSP, et al. Role of intestinal transit in the pathogenesis of gallbladder stones. Can J Gastroenterol1997;11:57.

123. HussainiSH, PereiraSP, DowlingRH, et al. Slow intestinal transit and gallstone formation. Lancet1993;341:638. CrossRef

124. HussainiSH, PereiraSP, MurphyGM, et al. Deoxycholic acid influences cholesterol solubilization and microcrystal nucleation time in gallbladder bile. Hepatology1995;22:1735.

125. HussainiSH, PereiraSP, VeyseyMJ, et al. Roles of gall bladder emptying and intestinal transit in the pathogenesis of octreotide induced gall bladder stones. Gut1996;38:775. CrossRef

126. HussainiSH, PereiraSP, MurphyGM, et al. Composition of gall bladder stones associated with octreotide: response to oral ursodeoxycholic acid. Gut1995;36:126. CrossRef

127. MaurerKJ, IhrigMM, RogersAB, et al. Identification of cholelithogenic enterohepatic helicobacter species and their role in murine cholesterol gallstone formation. Gastroenterology2005;128:1023. CrossRef

128. MaurerKJ, RogersAB, GeZ, et al. Helicobacter pylori and cholesterol gallstone formation in C57L/J mice: a prospective study. Am J Physiol Gastrointest Liver Physiol2006;290:G175. CrossRef

129. FoxJG, DewhirstFE, ShenZ, et al. Hepatic Helicobacter species identified in bile and gallbladder tissue from Chileans with chronic cholecystitis. Gastroenterology1998;114:755. CrossRef

130. van den BergAA, van BuulJD, OstrowJD, et al. Measurement of cholesterol gallstone growth in vitro. J Lipid Res2000;41:189.

131. WangHH, PortincasaP, Mendez‐SanchezN, et al. Effect of ezetimibe on the prevention and dissolution of cholesterol gallstones. Gastroenterology2008;134:2101. CrossRef

132. WangDQH, TazumaS. Effect of beta‐muricholic acid on the prevention and dissolution of cholesterol gallstones in C57L/J mice. J Lipid Res2002;43:1960. CrossRef

133. VitekL, CareyMC. New pathophysiological concepts underlying pathogenesis of pigment gallstones. Clin Res Hepatol Gastroenterol2012;36:122. CrossRef

134. OstrowJD. The etiology of pigment gallstones. Hepatology1984;4:215S. CrossRef

135. BosmaPJ, ChowdhuryJR, BakkerC, et al. The genetic basis of the reduced expression of bilirubin UDP‐glucuronosyltransferase 1 in Gilbert's syndrome. N Engl J Med1995;333:1171. CrossRef

136. VasavdaN, MenzelS, KondaveetiS, et al. The linear effects of alpha‐thalassaemia, the UGT1A1 and HMOX1 polymorphisms on cholelithiasis in sickle cell disease. Br J Haematol2007;138:263. CrossRef

137. WasmuthHE, KeppelerH, HerrmannU, et al. Coinheritance of Gilbert syndrome‐associated UGT1A1 mutation increases gallstone risk in cystic fibrosis. Hepatology2006;43:738. CrossRef

138. ChaarV, KeclardL, DiaraJP, et al. Association of UGT1A1 polymorphism with prevalence and age at onset of cholelithiasis in sickle cell anemia. Haematologica2005;90:188.

139. HaverfieldEV, McKenzieCA, ForresterT, et al. UGT1A1 variation and gallstone formation in sickle cell disease. Blood2005;105:968. CrossRef

140. JohnsonAD, KavousiM, SmithAV, et al. Genome‐wide association meta‐analysis for total serum bilirubin levels. Hum Mol Genet2009;18:2700. CrossRef

141. MatsushiroT. Identification of glucaro‐1,4‐lactone in bile as a factor responsible for inhibitory effect of bile on bacterial beta‐glucuronidase. Tohoku J Exp Med1965;85:330. CrossRef

142. HoKJ, HsuSC, ChenJS, et al. Human biliary beta‐glucuronidase: correlation of its activity with deconjugation of bilirubin in the bile. Eur J Clin Invest1986;16:361. CrossRef

143. ShodaJ, TanakaN, OsugaT. Hepatolithiasis–epidemiology and pathogenesis update. Front Biosci2003;8:e398. CrossRef

144. NakayamaF. Intrahepatic calculi: a special problem in East Asia. World J Surg1982;6:802. CrossRef

145. NakayamaF, FurusawaT, NakamaT. Hepatolithiasis in Japan: present status. Am J Surg1980;139:216. CrossRef

146. NakayamaF, KogaA. Hepatolithiasis: present status. World J Surg1984;8:9. CrossRef

147. NakayamaF, KogaA, IchimiyaH, et al. Hepatolithiasis in East Asia: comparison between Japan and China. J Gastroenterol Hepatol1991;6:155. CrossRef

148. NakayamaF, SolowayRD, NakamaT, et al. Hepatolithiasis in East Asia. Retrospective study. Dig Dis Sci1986;31:21. CrossRef

149. LevineSB, SamplinerRE, BennettPH, et al. Asymptomatic parotid enlargement in Pima Indians. Relationship to age, obesity, and diabetes mellitus. Ann Intern Med1970;73:571. CrossRef

150. WeissKM, FerrellRE, HanisCL, et al. Genetics and epidemiology of gallbladder disease in New World native peoples. Am J Hum Genet1984;36:1259.

151. van der LindenW, NakayamaF. Gallstone disease in Sweden versus Japan. Clinical and etiologic aspects. Am J Surg1973;125:267. CrossRef

152. DanzingerRG, GordonH, SchoenfieldLJ, et al. Lithogenic bile in siblings of young women with cholelithiasis. Mayo Clin Proc1972;47:762.

153. Antero KesaniemiY, KoskenvuoM, VuoristoM, et al. Biliary lipid composition in monozygotic and dizygotic pairs of twins. Gut1989;30:1750. CrossRef

154. WangDQ. Aging per se is an independent risk factor for cholesterol gallstone formation in gallstone susceptible mice. J Lipid Res2002;43:1950. CrossRef

155. BiddingerSB, HaasJT, YuBB, et al. Hepatic insulin resistance directly promotes formation of cholesterol gallstones. Nat Med2008;14:778. CrossRef

156. WangHH, AfdhalNH, WangDQ. Overexpression of estrogen receptor alpha increases hepatic cholesterogenesis, leading to biliary hypersecretion in mice. J Lipid Res2006;47:778. CrossRef

157. HyogoH, RoyS, PaigenB, et al. Leptin promotes biliary cholesterol elimination during weight loss in ob/ob mice by regulating the enterohepatic circulation of bile salts. J Biol Chem2002;277:34117. CrossRef

158. EversonGT, McKinleyC, KernFJr. Mechanisms of gallstone formation in women. Effects of exogenous estrogen (Premarin) and dietary cholesterol on hepatic lipid metabolism. J Clin Invest1991;87:237. CrossRef

159. YangH, PetersenGM, RothMP, et al. Risk factors for gallstone formation during rapid loss of weight. Dig Dis Sci1992;37:912. CrossRef

160. KrawczykM, WangDQ, PortincasaP, et al. Dissecting the genetic heterogeneity of gallbladder stone formation. Semin Liver Dis2011;31:157. CrossRef

161. DuggiralaR, MitchellBD, BlangeroJ, et al. Genetic determinants of variation in gallbladder disease in the Mexican‐American population. Genet Epidemiol1999;16:191. CrossRef

162. NakeebA, ComuzzieAG, MartinL, et al. Gallstones: genetics versus environment. Ann Surg2002;235:842. CrossRef

163. KatsikaD, GrjibovskiA, EinarssonC, et al. Genetic and environmental influences on symptomatic gallstone disease: a Swedish study of 43,141 twin pairs. Hepatology2005;41:1138. CrossRef

164. GrunhageF, AcalovschiM, TirziuS, et al. Increased gallstone risk in humans conferred by common variant of hepatic ATP‐binding cassette transporter for cholesterol. Hepatology2007;46:793. CrossRef

165. WangY, JiangZY, FeiJ, et al. ATP binding cassette G8 T400K polymorphism may affect the risk of gallstone disease among Chinese males. Clin Chim Acta2007;384:80. CrossRef

166. KuoKK, ShinSJ, ChenZC, et al. Significant association of ABCG5 604Q and ABCG8 D19H polymorphisms with gallstone disease. Br J Surg2008;95:1005. CrossRef

167. RudkowskaI, JonesPJ. Polymorphisms in ABCG5/G8 transporters linked to hypercholesterolemia and gallstone disease. Nutr Rev2008;66:343. CrossRef

168. KatsikaD, MagnussonP, KrawczykM, et al. Gallstone disease in Swedish twins: risk is associated with ABCG8 D19H genotype. J Intern Med2010;268:279. CrossRef

169. StenderS, Frikke‐SchmidtR, NordestgaardBG, et al. Sterol transporter adenosine triphosphate‐binding cassette transporter G8, gallstones, and biliary cancer in 62,000 individuals from the general population. Hepatology2011;53:640. CrossRef

170. XuHL, ChengJR, AndreottiG, et al. Cholesterol metabolism gene polymorphisms and the risk of biliary tract cancers and stones: a population‐based case‐control study in Shanghai, China. Carcinogenesis2011;32:58. CrossRef

171. von KampenO, BuchS, NothnagelM, et al. Genetic and functional identification of the likely causative variant for cholesterol gallstone disease at the ABCG5/8 lithogenic locus. Hepatology2012;57:2407. CrossRef

172. RosmorducO, HermelinB, PouponR. MDR3 gene defect in adults with symptomatic intrahepatic and gallbladder cholesterol cholelithiasis. Gastroenterology2001;120:1459. CrossRef

173. JacqueminE, De VreeJM, CresteilD, et al. The wide spectrum of multidrug resistance 3 deficiency: from neonatal cholestasis to cirrhosis of adulthood. Gastroenterology2001;120:1448. CrossRef

174. KrawczykM, LutjohannD, Schirin‐SokhanR, et al. Phytosterol and cholesterol precursor levels indicate increased cholesterol excretion and biosynthesis in gallstone disease. Hepatology2012;55:1507. CrossRef

175. PortincasaP, WangDQ. Intestinal absorption, hepatic synthesis, and biliary secretion of cholesterol: where are we for cholesterol gallstone formation?Hepatology2012;55:1313. CrossRef

176. WangHH, PortincasaP, de BariO, et al. Prevention of cholesterol gallstones by inhibiting hepatic biosynthesis and intestinal absorption of cholesterol. Eur J Clin Invest2013;43:413. CrossRef

177. de BariO, Neuschwander‐TetriBA, LiuM, et al. Ezetimibe: its novel effects on the prevention and the treatment of cholesterol gallstones and nonalcoholic Fatty liver disease. J Lipids2012;2012:302847. CrossRef

178. MillerLJ, HolickyEL, UlrichCD, et al. Abnormal processing of the human cholecystokinin receptor gene in association with gallstones and obesity. Gastroenterology1995;109:1375. CrossRef

179. SchneiderH, SangerP, HanischE. In vitro effects of cholecystokinin fragments on human gallbladders. Evidence for an altered CCK‐receptor structure in a subgroup of patients with gallstones. J Hepatol1997;26:1063. CrossRef

180. NardoneG, FerberIA, MillerLJ. The integrity of the cholecystokinin receptor gene in gallbladder disease and obesity. Hepatology1995;22:1751.

181. JuvonenT, KervinenK, KairaluomaMI, et al. Gallstone cholesterol content is related to apolipoprotein E polymorphism. Gastroenterology1993;104:1806.

182. BertomeuA, RosE, ZambonD, et al. Apolipoprotein E polymorphism and gallstones. Gastroenterology1996;111:1603. CrossRef

183. Van ErpecumKJ, Van Berge‐henegouwenGP, EckhardtER, et al. Cholesterol crystallization in human gallbladder bile: relation to gallstone number, bile composition, and apolipoprotein E4 isoform. Hepatology1998;27:1508. CrossRef

184. FischerS, DoluMH, ZundtB, et al. Apolipoprotein E polymorphism and lithogenic factors in gallbladder bile. Eur J Clin Invest2001;31:789. CrossRef

185. MellaJG, Schirin‐SokhanR, RigottiA, et al. Genetic evidence that apolipoprotein E4 is not a relevant susceptibility factor for cholelithiasis in two high‐risk populations. J Lipid Res2007;48:1378. CrossRef

186. KesaniemiYA, EhnholmC, MiettinenTA. Intestinal cholesterol absorption efficiency in man is related to apoprotein E phenotype. J Clin Invest1987;80:578. CrossRef

187. JuvonenT, SavolainenMJ, KairaluomaMI, et al. Polymorphisms at the apoB, apoA‐I, and cholesteryl ester transfer protein gene loci in patients with gallbladder disease. J Lipid Res1995;36:804.

188. HanT, JiangZ, SuoG, et al. Apolipoprotein B‐100 gene Xba I polymorphism and cholesterol gallstone disease. Clin Genet2000;57:304. CrossRef

189. RennerO, HarschS, StrohmeyerA, et al. Reduced ileal expression of OSTalpha‐OSTbeta in non‐obese gallstone disease. J Lipid Res2008;49:2045. CrossRef

190. BergheimI, HarschS, MuellerO, et al. Apical sodium bile acid transporter and ileal lipid binding protein in gallstone carriers. J Lipid Res2006;47:42. CrossRef

191. RennerO, HarschS, SchaeffelerE, et al. A variant of the SLC10A2 gene encoding the apical sodium‐dependent bile acid transporter is a risk factor for gallstone disease. PLoS ONE2009;4:e7321. CrossRef

192. TonjesA, WittenburgH, HalbritterJ, et al. Effects of SLC10A2 variant rs9514089 on gallstone risk and serum cholesterol levels‐ meta‐analysis of three independent cohorts. BMC Med Genet2011;12:149. CrossRef

193. BarbaraL, SamaC, Morselli LabateAM, et al. A population study on the prevalence of gallstone disease: the Sirmione Study. Hepatology1987;7:913. CrossRef

194. AttiliAF, De SantisA, CapriR, et al. The natural history of gallstones: the GREPCO experience. Hepatology1995;21:656. CrossRef

195. GlambekI, KvaaleG, ArnesjoB, et al. Prevalence of gallstones in a Norwegian population. Scand J Gastroenterol1987;22:1089. CrossRef

196. SchmidtM, HauskenT, GlambekI, et al. A 24‐year controlled follow‐up of patients with silent gallstones showed no long‐term risk of symptoms or adverse events leading to cholecystectomy. Scand J Gastroenterol2011;46:949. CrossRef

197. GibneyEJ. Asymptomatic gallstones. Br J Surg1990;77:368. CrossRef

198. GracieWA, RansohoffDF. The natural history of silent gallstones: the “innocent” gallstone” is not a myth. N Engl J Med1982;307:798. CrossRef

199. FriedmanGD. Natural history of asymptomatic and symptomatic gallstones. Am J Surg1993;165:399. CrossRef

200. Del FaveroG, CaroliA, MeggiatoT, et al. Natural history of gallstones in non‐insulin‐dependent diabetes mellitus. A prospective 5‐year follow‐up. Dig Dis Sci1994;39:1704. CrossRef

201. ThistleJL, ClearyPA, LachinJM, et al. The natural history of cholelithiasis: the National Cooperative Gallstone Study. Ann Intern Med1984;101:171. CrossRef

202. FriedmanGD, RaviolaCA, FiremanB. Prognosis of gallstones with mild or no symptoms: 25 years of follow‐up in a health maintenance organization. J Clin Epidemiol1989;42:127. CrossRef

203. PortincasaP, Di CiaulaA, BaldassarreG, et al. Gallbladder motor function in gallstone patients: sonographic and in vitro studies on the role of gallstones, smooth muscle function and gallbladder wall inflammation. J Hepatol1994;21:430. CrossRef

204. van ErpecumKJ, vanBerge‐HenegouwenGP, StolkMFJ, et al. Fasting gallbladder volume, postprandial emptying and cholecystokinin release in gallstone patients and normal subjects. J Hepatol1992;14:194. CrossRef

205. ColecchiaA, SandriL, Bacchi‐ReggianiML, et al. Is it possible to predict the clinical course of gallstone disease? Usefulness of gallbladder motility evaluation in a clinical setting. Am J Gastroenterol2006;101:2576. CrossRef

206. SobolevB, MercerD, BrownP, et al. Risk of emergency admission while awaiting elective cholecystectomy. CMAJ2003;169:662.

207. SchoenfieldLJ, CarulliN, DowlingRH, et al. Asymptomatic gallstones: definition and treatment. Gastroenterol Int1989;2:25.

208. BergerMY, van der VldenJJ, LijmerJG, et al. Abdominal symptoms: do they predict gallstones? A systematic review. Scand J Gastroenterol2000;35:70. CrossRef

209. KraagN, ThijsC, KnipschildP. Dyspepsia: how noisy are gallstones? A meta‐analysis of epidemiologic studies of biliary pain, dyspeptic symptoms, and food intolerance. Scand J Gastroenterol1995;30:411. CrossRef

210. GuiGP, CheruvuCV, WestN, et al. Is cholecystectomy effective treatment for symptomatic gallstones? Clinical outcome after long‐term follow‐up. Ann R Coll Surg Engl1998;80:25.

211. FensterLF, LonborgR, ThirlbyRC, et al. What symptoms does cholecystectomy cure? Insights from an outcomes measurement project and review of the literature. Am J Surg1995;169:533. CrossRef

212. WeinertCR, ArnettD, JacobsDJr, et al.Relationship between persistence of abdominal symptoms and successful outcome after cholecystectomy. Arch Intern Med2000;160:989. CrossRef

213. PortincasaP, Di CiaulaA, PalmieriVO, et al. Impaired gallbladder and gastric motility and pathological gastro‐esophageal reflux in gallstone patients. Eur J Clin Invest1997;8:653. CrossRef

214. MurphyJB. The diagnosis of gall‐stones. Am Med News1903;82:825.

215. YarmishGM, SmithMP, RosenMP, et al.; Expert Panel on Gastrointestinal Imaging. ACR Appropriateness Criteria® right upper quadrant pain. National Guideline Clearinghouse. American College of Radiology (ACR); 2013. Rockville MD: Agency for Healthcare Research and Quality (AHRQ). Available at: http://www.guideline.gov/content.aspx?id=47653. Accessed Dec 2014.

216. SheaJA, BerlinJA, EscarceJJ, et al. Revised estimates of diagnostic test sensitivity and specificity in suspected biliary tract disease. Arch Intern Med1994;154:2573. CrossRef

217. PalascianoG, PortincasaP, VinciguerraV, et al. Gallstone prevalence and gallbladder volume in children and adolescents: an epidemiological ultrasonographic survey and relationship to body mass index. Am J Gastroenterol1989;84:1378.

218. PalascianoG, SerioG, PortincasaP, et al. Gallbladder volume in adults, and relationship to age, sex, body mass index, and gallstones: a sonographic population study. Am J Gastroenterol1992;87:493.

219. LeopoldGR, AmbergJ, GosinkBB, et al. Gray scale ultrasonic cholecystography: a comparison with conventional radiographic techniques. Radiology1976;121:445. CrossRef

220. LeopoldGR. Diagnostic ultrasound. JAMA1976;236:2394. CrossRef

221. ConradMR, JanesJO, DietchyJ. Significance of low level echoes within the gallbladder. AJR Am J Roentgenol1979;132:967. CrossRef

222. PortincasaP, Di CiaulaA, PalmieriVO, et al. Sonographic evaluation of gallstone burden in humans. Ital J Gastroenterol Hepatol1994;26:141.

223. BrinkJA, SimeoneJF, MuellerPR, et al. Physical characteristics of gallstones removed at cholecystectomy: implications for extracorporeal shock‐wave lithotripsy. AJR Am J Roentgenol1988;151:927. CrossRef

224. FillyRA, AllenB, MintonMJ, et al. In vitro investigation of the origin of echoes with biliary sludge. J Clin Ultrasound1980;8:193. CrossRef

225. BarakosJA, RallsPW, LapinSA, et al. Cholelithiasis: evaluation with CT. Radiology1987;162:415. CrossRef

226. CaroliA, Del FaveroG, Di MarioF, et al. Computed tomography in predicting gall stone solubility: a prospective trial. Gut1992;33:698. CrossRef

227. PereiraSP, VeyseyMJ, KennedyC, et al. Gallstone dissolution with oral bile acid therapy – Importance of pretreatment CT scanning and reasons for nonresponse. Dig Dis Sci1997;42:1775. CrossRef

228. PetroniML, JazrawiRP, GrundyA, et al. Prospective, multicenter study on value of computerized tomography (CT) in gallstone disease in predicting response to bile acid therapy. Dig Dis Sci1995;40:1956. CrossRef

229. RomagnuoloJ, BardouM, RahmeE, et al. Magnetic resonance cholangiopancreatography: a meta‐analysis of test performance in suspected biliary disease. Ann Intern Med2003;139:547. CrossRef

230. TaitN, LittleJM. The treatment of gall stones. BMJ1995;311:99. CrossRef

231. HofmannAF, AmelsbergA, VansonnenbergE. Pathogenesis and treatment of gallstones. N Engl J Med1993;328:1854. CrossRef

232. JohnstonDE, KaplanMM. Pathogenesis and treatment of gallstones. N Engl J Med1993;328:412. CrossRef

233. PaumgartnerG, Carr‐LockeDL, DuboisF, et al. Strategies in the treatment of gallstone disease. Working team report. Gastroenterol Int1993;6:65.

234. BruggeWR. The silent gallstone. In: AfdhalNH(ed). Gallbladder and Biliary Tract Diseases. New York, Basel: Marcel Dekker, Inc.; 2000: 447.

235. KumarA, DeedJS, BhasinB, et al. Comparison of the effect of diclofenac with hyoscine‐N‐butylbromide in the symptomatic treatment of acute biliary colic. ANZ J Surg2004;74:573. CrossRef

236. ColliA, ConteD, ValleSD, et al. Meta‐analysis: nonsteroidal anti‐inflammatory drugs in biliary colic. Aliment Pharmacol Ther2012;35:1370. CrossRef

237. Al‐WailiN, SaloomKY. The analgesic effect of intravenous tenoxicam in symptomatic treatment of biliary colic: a comparison with hyoscine N‐butylbromide. Eur J Med Res1998;3:475.

238. AkriviadisEA, HatzigavrielM, KapniasD, et al. Treatment of biliary colic with diclofenac: a randomized, double‐blind, placebo‐controlled study. Gastroenterology1997;113:225. CrossRef

239. GoldmanG, KahnPJ, AlonR, et al. Biliary colic treatment and acute cholecystitis prevention by prostaglandin inhibitor. Dig Dis Sci1989;34:809. CrossRef

240. EltaGH, BarnettJL. Meperidine need not be proscribed during sphincter of Oddi manometry. Gastrointest Endosc1994;40:7. CrossRef

241. OlsenJC, McGrathNA, SchwarzDG, et al. A double‐blind randomized clinical trial evaluating the analgesic efficacy of ketorolac versus butorphanol for patients with suspected biliary colic in the emergency department. Acad Emerg Med2008;15:718. CrossRef

242. KeusF, de JongJA, GooszenHG, et al. Small‐incision versus open cholecystectomy for patients with symptomatic cholecystolithiasis. Cochrane Database Syst Rev2006;(4):CD004788.

243. KeusF, de JongJA, GooszenHG, et al. Laparoscopic versus open cholecystectomy for patients with symptomatic cholecystolithiasis. Cochrane Database Syst Rev2006;(4):CD006231.

244. KeusF, de JongJA, GooszenHG, et al. Laparoscopic versus small‐incision cholecystectomy for patients with symptomatic cholecystolithiasis. Cochrane Database Syst Rev2006;(4):CD006229.

245. OverbyDW, ApelgrenKN, RichardsonW, et al.; Society of American Gastrointestinal and Endoscopic Surgeons (SAGES). SAGES guidelines for the clinical application of laparoscopic biliary tract surgery. Surg Endosc2010;24:2368. CrossRef

246. Society of American Gastrointestinal and Endoscopic Surgeons (SAGES). SAGES guidelines for the clinical application of laparoscopic biliary tract surgery. Rockville MD: Los Angeles, CA: Society of American Gastrointestinal and Endoscopic Surgeons (SAGES); 2010. Available at: http://www.guideline.gov/content.aspx?id=16258&search=laparoscopic; Accessed Dec 2014.

247. LammertF, NeubrandMW, BittnerR, et al. [S3‐guidelines for diagnosis and treatment of gallstones. German Society for Digestive and Metabolic Diseases and German Society for Surgery of the Alimentary Tract]. Z Gastroenterol2007;45:971. CrossRef

248. GurusamyKS, SamrajK, FusaiG, et al. Robot assistant versus human or another robot assistant in patients undergoing laparoscopic cholecystectomy. Cochrane Database Syst Rev2012;(9):CD006578.

249. SanabriaA, DominguezLC, ValdiviesoE, et al. Antibiotic prophylaxis for patients undergoing elective laparoscopic cholecystectomy. Cochrane Database Syst Rev2010;(12):CD005265.

250. GigerUF, MichelJM, OpitzI, et al. Risk factors for perioperative complications in patients undergoing laparoscopic cholecystectomy: analysis of 22,953 consecutive cases from the Swiss Association of Laparoscopic and Thoracoscopic Surgery database. J Am Coll Surg2006;203:723. CrossRef

251. TuveriM, TuveriA. Laparoscopic cholecystectomy: complications and conversions with the 3‐trocar technique: a 10‐year review. Surg Laparosc Endosc Percutan Tech2007;17:380. CrossRef

252. DucaS, BalaO, Al‐HajjarN, et al. Laparoscopic cholecystectomy: incidents and complications. A retrospective analysis of 9542 consecutive laparoscopic operations. HPB (Oxford)2003;5:152. CrossRef

253. VetrhusM, SoreideO, SolhaugJH, et al. Symptomatic, non‐complicated gallbladder stone disease. Operation or observation? A randomized clinical study. Scand J Gastroenterol2002;37:834. CrossRef

254. PokornyWJ, SaleemM, O'GormanRB, et al. Cholelithiasis and cholecystitis in childhood. Am J Surg1984;148:742. CrossRef

255. GumieroAP, Bellomo‐BrandaoMA, Costa‐PintoEA. Gallstones in children with sickle cell disease followed up at a Brazilian hematology center. Arq Gastroenterol2008;45:313. CrossRef

256. BogueCO, MurphyAJ, GerstleJT, et al. Risk factors, complications, and outcomes of gallstones in children: a single‐center review. J Pediatr Gastroenterol Nutr2010;50:303. CrossRef

257. ChanS, CurrieJ, MalikAI, et al. Paediatric cholecystectomy: shifting goalposts in the laparoscopic era. Surg Endosc2008;22:1392. CrossRef

258. VennemanNG, RenooijW, RehfeldJF, et al. Small gallstones, preserved gallbladder motility, and fast crystallization are associated with pancreatitis. Hepatology2005;41:738. CrossRef

259. AmaralJF, ThompsonWR. Gallbladder disease in the morbidly obese. Am J Surg1985;149:551. CrossRef

260. SleisengerMH, FordtranJS. Gastrointestinal Disease: Pathophysiology, Diagnosis, Management, 8th edn. Philadelphia: W.B. Saunders; 2006.

261. LowenfelsAB, WalkerAM, AlthausDP, et al. Gallstone growth, size, and risk of gallbladder cancer: an interracial study. Int J Epidemiol1989;18:50. CrossRef

262. RandiG, FranceschiS, La VecchiaC. Gallbladder cancer worldwide: geographical distribution and risk factors. Int J Cancer2006;118:1591. CrossRef

263. AshurH, SiegalB, OlandY, et al. Calcified ballbladder (porcelain gallbladder). Arch Surg1978;113:594. CrossRef

264. LowenfelsAB, LindstromCG, ConwayMJ, et al. Gallstones and risk of gallbladder cancer. J Natl Cancer Inst1985;75:77.

265. BonatsosG, BirbasK, ToutouzasK, et al. Laparoscopic cholecystectomy in adults with sickle cell disease. Surg Endosc2001;15:816. CrossRef

266. MakinoI, ShinozakiK, YoshinoK, et al. [Dissolution of cholesterol gallstones by long‐term administration of ursodeoxycholic acid]. Nippon Shokakibyo Gakkai Zasshi1975;72:690.

267. PaumgartnerG, PauletzkiJ, SackmannM. Ursodeoxycholic acid treatment of cholesterol gallstone disease. Scand J Gastroenterol Suppl1994;204:27. CrossRef

268. PortincasaP, MoschettaA, PetruzzelliM, et al. Gallstone disease: symptoms and diagnosis of gallbladder stones. Best Pract Res Clin Gastroenterol2006;20:1017. CrossRef

269. van ErpecumKJ, PortincasaP, StolkMFJ, et al. Effects of bile salt and phospholipid hydrophobicity on lithogenicity of human gallbladder bile. Eur J Clin Invest1994;24:744. CrossRef

270. van ErpecumKJ, PortincasaP, GadellaaM, et al. Effects of bile salt hydrophobicity on nucleation behaviour of cholesterol crystals in model bile. Eur J Clin Invest1996;26:602. CrossRef

271. PortincasaP, van ErpecumKJ, JansenA, et al. Behavior of various cholesterol crystals in bile from gallstone patients. Hepatology1996;23:738. CrossRef

272. KupferRM, MaudgalDP, NorthfieldTC. Gallstone dissolution rate during chenic acid therapy. Effect of bedtime administration plus low cholesterol diet. Dig Dis Sci1982;27:1025. CrossRef

273. LanziniA, FacchinettiD, NorthfieldTC. Maintenance of hepatic bile acid secretion rate during overnight fasting by bedtime bile acid administration. Gastroenterology1988;95:1029.

274. PortincasaP, Di CiaulaA, BonfrateL, et al. Therapy of gallstone disease: what it was, what it is, what it will be. World J Gastrointest Pharmacol Ther2012;3:7. CrossRef

275. EversonGT, BravermanDZ, JohnsonML, et al. A critical evaluation of real‐time ultrasonography for the study of gallbladder volume and contraction. Gastroenterology1980;79:40.

276. PortincasaP, MoschettaA, ColecchiaA, et al. Measurement of gallbladder motor function by ultrasonography: towards for standardization. Dig Liver Dis2003;35(Suppl 3):S56. CrossRef

277. PauletzkiJG, AlthausR, HollJ, et al. Gallbladder emptying and gallstone formation: a prospective study on gallstone recurrence. Gastroenterology1996;111:765. CrossRef

278. PortincasaP, van ErpecumKJ, van de MeebergPC, et al. Apolipoprotein (Apo) E4 genotype and galbladder motility influence speed of gallstone clearance and risk of recurrence after extracorporeal shock‐wave lithotripsy. Hepatology1996;24:580. CrossRef

279. VennemanNG, vanBerge‐HenegouwenGP, PortincasaP, et al. Absence of apolipoprotein E4 genotype, good gallbladder motility and presence of solitary stones delay rather than prevent gallstone recurrence after extracorporeal shock wave lithotripsy. J Hepatol2001;35:10. CrossRef

280. FestiD, FrabboniR, BazzoliF, et al. Gallbladder motility in cholesterol gallstone disease. Effect of ursodeoxycholic acid administration and gallstone dissolution. Gastroenterology1990;99:1779.

281. PereiraSP, HussainiSH, KennedyC, et al. Gallbladder stone recurrence after medical treatment. Do gallstones recur true to type?Dig Dis Sci1995;40:2568. CrossRef

282. SeniorJR, JohnsonMF, DeTurckDM, et al. In vivo kinetics of radiolucent gallstone dissolution by oral dihydroxy bile acids. Gastroenterology1990;99:243.

283. JazrawiRP, PigozziMG, GalatolaG, et al. Optimum bile acid treatment for rapid gall stone dissolution. Gut1992;33:381. CrossRef

284. PaumgartnerG. Therapeutic options and choice of appropriate treatment. In: FrommH, LeuschnerU(eds). Bile Acids – Cholestasis – Gallstones. Advances in Basic and Clinical Bile Acid Research. Dordrecht: Kluwer Academic Publishers; 1996: 205.

285. LanziniA, JazrawiRP, KupferRM, et al. Gallstone recurrence after medical dissolution. An overestimated threat?J Hepatol1986;3:241. CrossRef

286. RabensteinT, Radespiel‐TrogerM, HopfnerL, et al. Ten years experience with piezoelectric extracorporeal shockwave lithotripsy of gallbladder stones. Eur J Gastroenterol Hepatol2005;17:629. CrossRef

287. BatesonMC, BouchierIA, TrashDB, et al. Calcification of radiolucent gall stone during treatment with ursodeoxycholic acid. Br Med J (Clin Res Ed)1981;283:645. CrossRef

288. VillanovaN, BazzoliF, TaroniF, et al. Gallstone recurrence after successful oral bile acid treatment: a 12 year follow‐up study and evaluation of long term postdissolution treatment. Gastroenterology1989;97:726.

289. EversonGT. Gastrointestinal motility in pregnancy. Gastroenterol Clin North Am1992;21:751.

290. CosenzaCA, SaffariB, JabbourN, et al. Surgical management of biliary gallstone disease during pregnancy. Am J Surg1999;178:545. CrossRef

291. DavisA, KatzVL, CoxR. Gallbladder disease in pregnancy. J Reprod Med1995;40:759.

292. OthmanMO, StoneE, HashimiM, et al. Conservative management of cholelithiasis and its complications in pregnancy is associated with recurrent symptoms and more emergency department visits. Gastrointest Endosc2012;76:564. CrossRef

293. DateRS, KaushalM, RameshA. A review of the management of gallstone disease and its complications in pregnancy. Am J Surg2008;196:599. CrossRef

294. MaringhiniA, CiambraM, BaccelliereP, et al. Biliary sludge and gallstones in pregnancy: incidence, risk factors, and natural history. Ann Intern Med1993;119:116. CrossRef

295. ValdiviesoV, CovarrubiasC, SiegelF, et al. Pregnancy and cholelithiasis: pathogenesis and natural course of gallstones diagnosed in early puerperium [see comments]. Hepatology1993;17:1.

296. European Association for the Study of the Liver. EASL Clinical Practice Guidelines: management of cholestatic liver diseases. J Hepatol2009;51:237. CrossRef

297. ThamTC, VandervoortJ, WongRC, et al. Safety of ERCP during pregnancy. Am J Gastroenterol2003;98:308. CrossRef

298. Di CiaulaA, WangDQ, WangHH, et al. Targets for current pharmacologic therapy in cholesterol gallstone disease. Gastroenterol Clin North Am2010;39:245. CrossRef

299. KochM, GardenOJ, PadburyR, et al. Bile leakage after hepatobiliary and pancreatic surgery: a definition and grading of severity by the International Study Group of Liver Surgery. Surgery2011;149:680. CrossRef

300. TulchinskyM, CiakBW, DelbekeD, et al. SNM practice guideline for hepatobiliary scintigraphy 4.0. J Nucl Med Technol2010;38:210. CrossRef

301. SauerlandS, AgrestaF, BergamaschiR, et al. Laparoscopy for abdominal emergencies: evidence‐based guidelines of the European Association for Endoscopic Surgery. Surg Endosc2006;20:14. CrossRef

302. MiuraF, TakadaT, KawaradaY, et al. Flowcharts for the diagnosis and treatment of acute cholangitis and cholecystitis: Tokyo Guidelines. J Hepatobiliary Pancreat Surg2007;14:27. CrossRef

303. HirotaM, TakadaT, KawaradaY, et al. Diagnostic criteria and severity assessment of acute cholecystitis: Tokyo Guidelines. J Hepatobiliary Pancreat Surg2007;14:78. CrossRef

304. TsuyuguchiT, TakadaT, KawaradaY, et al. Techniques of biliary drainage for acute cholecystitis: Tokyo Guidelines. J Hepatobiliary Pancreat Surg2007;14:46. CrossRef

305. YoshidaM, TakadaT, KawaradaY, et al. Antimicrobial therapy for acute cholecystitis: Tokyo Guidelines. J Hepatobiliary Pancreat Surg2007;14:83. CrossRef

306. KimuraY, TakadaT, KawaradaY, et al. Definitions, pathophysiology, and epidemiology of acute cholangitis and cholecystitis: Tokyo Guidelines. J Hepatobiliary Pancreat Surg2007;14:15. CrossRef

307. SekimotoM, TakadaT, KawaradaY, et al. Need for criteria for the diagnosis and severity assessment of acute cholangitis and cholecystitis: Tokyo Guidelines. J Hepatobiliary Pancreat Surg2007;14:11. CrossRef

308. TakadaT, KawaradaY, NimuraY, et al. Background: Tokyo Guidelines for the management of acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Surg2007;14:1. CrossRef

309. MayumiT, TakadaT, KawaradaY, et al. Results of the Tokyo Consensus Meeting Tokyo Guidelines. J Hepatobiliary Pancreat Surg2007;14:114. CrossRef

310. BariePS, EachempatiSR. Acute acalculous cholecystitis. Gastroenterol Clin North Am2010;39:343. CrossRef

311. ChoJY, HanHS, YoonYS, et al. Risk factors for acute cholecystitis and a complicated clinical course in patients with symptomatic cholelithiasis. Arch Surg2010;145:329. CrossRef

312. BarclayAW, PetoczP, McMillan‐PriceJ, et al. Glycemic index, glycemic load, and chronic disease risk–a meta‐analysis of observational studies. Am J Clin Nutr2008;87:627.

313. HulleyS, FurbergC, Barrett‐ConnorE, et al. Noncardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow‐up (HERS II). JAMA2002;288:58. CrossRef

314. CirilloDJ, WallaceRB, RodaboughRJ, et al. Effect of estrogen therapy on gallbladder disease. JAMA2005;293:330. CrossRef

315. HulleyS, GradyD, BushT, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA1998;280:605. CrossRef

316. LiuB, BeralV, BalkwillA, et al. Gallbladder disease and use of transdermal versus oral hormone replacement therapy in postmenopausal women: prospective cohort study. BMJ2008;337:a386. CrossRef

317. ReissR, NudelmanI, GutmanC, et al. Changing trends in surgery for acute cholecystitis. World J Surg1990;14:567. CrossRef

318. CarrascosaMF, Salcines‐CaviedesJR. Emphysematous cholecystitis. CMAJ2012;184:E81. CrossRef

319. YokoeM, TakadaT, StrasbergSM, et al. New diagnostic criteria and severity assessment of acute cholecystitis in revised Tokyo Guidelines. J Hepatobiliary Pancreat Sci2012;19:578. CrossRef

320. SingerAJ, McCrackenG, HenryMC, et al. Correlation among clinical, laboratory, and hepatobiliary scanning findings in patients with suspected acute cholecystitis. Ann Emerg Med1996;28:267. CrossRef

321. MiuraF, TakadaT, StrasbergSM, et al. TG13 flowchart for the management of acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci2013;20:47. CrossRef

322. KiewietJJ, LeeuwenburghMM, BipatS, et al. A systematic review and meta‐analysis of diagnostic performance of imaging in acute cholecystitis. Radiology2012;264:708. CrossRef

323. BingenerJ, SchwesingerWH, ChopraS, et al. Does the correlation of acute cholecystitis on ultrasound and at surgery reflect a mirror image?Am J Surg2004;188:703. CrossRef

324. ParkMS, YuJS, KimYH, et al. Acute cholecystitis: comparison of MR cholangiography and US. Radiology1998;209:781. CrossRef

325. FidlerJ, PaulsonEK, LayfieldL. CT evaluation of acute cholecystitis: findings and usefulness in diagnosis. AJR Am J Roentgenol1996;166:1085. CrossRef

326. ShakespearJS, ShaabanAM, RezvaniM. CT findings of acute cholecystitis and its complications. AJR Am J Roentgenol2010;194:1523. CrossRef

327. GurusamyKS, DavidsonC, GluudC, et al.Early versus delayed laparoscopic cholecystectomy for people with acute cholecystitis.Cochrane Database Syst Rev2013;(6):CD005440.

328. RiallTS, ZhangD, TownsendCMJr, et al.Failure to perform cholecystectomy for acute cholecystitis in elderly patients is associated with increased morbidity, mortality, and cost. J Am Coll Surg2010;210:668. CrossRef

329. ZafarSN, ObirizeA, AdesibikanB, et al. Optimal time for early laparoscopic cholecystectomy for acute cholecystitis. JAMA Surg doi: 10.1001/jamasurg.2014.2339. [Epub ahead of print].

330. GuttCN, EnckeJ, KoningerJ, et al. Acute cholecystitis: early versus delayed cholecystectomy, a multicenter randomized trial (ACDC study, NCT00447304).Ann Surg2013;258:385. CrossRef

331. ReisnerRM, CohenJR. Gallstone ileus: a review of 1001 reported cases. Am Surg1994;60:441.

332. KallooAN, KantsevoySV. Gallstones and biliary disease. Prim Care2001;28:591. CrossRef

333. NahrwoldDL, RoseRC, WardSP. Abnormalities in gallbladder morphology and function in patients with cholelithiasis. Ann Surg1976;184:415. CrossRef

334. ScobieBA, SummerskillWH. Hepatic cirrhosis secondary to obstruction of the biliary system. Am J Dig Dis1965;10:135. CrossRef

335. MapleJT, Ben‐MenachemT, AndersonMA, et al.; American Society for Gastrointestinal Endoscopy (ASGE) Standards of Practice Committee. The role of endoscopy in the evaluation of suspected choledocholithiasis. Gastrointest Endosc2010;71:1. CrossRef

336. BrownLM, RogersSJ, CelloJP, et al. Cost‐effective treatment of patients with symptomatic cholelithiasis and possible common bile duct stones. J Am Coll Surg2011;212:1049. CrossRef

337. O'ConnorHJ, HamiltonI, EllisWR, et al. Ultrasound detection of choledocholithiasis: prospective comparison with ERCP in the postcholecystectomy patient. Gastrointest Radiol1986;11:161. CrossRef

338. LaingFC, JeffreyRB, WingVW. Improved visualization of choledocholithiasis by sonography. AJR Am J Roentgenol1984;143:949. CrossRef

339. EinsteinDM, LapinSA, RallsPW, et al. The insensitivity of sonography in the detection of choledocholithiasis. AJR Am J Roentgenol1984;142:725. CrossRef

340. AbboudPA, MaletPF, BerlinJA, et al. Predictors of common bile duct stones prior to cholecystectomy: a meta‐analysis. Gastrointest Endosc1996;44:450. CrossRef

341. SalemS, VasW. Ultrasonography in evaluation of the jaundiced patient. J Can Assoc Radiol1981;32:30.

342. Ledro‐CanoD. Suspected choledocholithiasis: endoscopic ultrasound or magnetic resonance cholangio‐pancreatography? A systematic review. Eur J Gastroenterol Hepatol2007;19:1007. CrossRef

343. VermaD, KapadiaA, EisenGM, et al. EUS vs MRCP for detection of choledocholithiasis. Gastrointest Endosc2006;64:248. CrossRef

344. SotoJA, AlvarezO, MuneraF, et al. Diagnosing bile duct stones: comparison of unenhanced helical CT, oral contrast‐enhanced CT cholangiography, and MR cholangiography. AJR Am J Roentgenol2000;175:1127. CrossRef

345. FangY, GurusamyKS, WangQ, et al. Pre‐operative biliary drainage for obstructive jaundice. Cochrane Database Syst Rev2012;(9):CD005444.

346. RogersSJ, CelloJP, HornJK, et al. Prospective randomized trial of LC+LCBDE vs ERCP/S+LC for common bile duct stone disease. Arch Surg2010;145:28.

347. YinZ, XuK, SunJ, et al. Is the end of the T‐tube drainage era in laparoscopic choledochotomy for common bile duct stones is coming? A systematic review and meta‐analysis. Ann Surg2013;257:54. CrossRef

348. McAlisterVC, DavenportE, RenoufE. Cholecystectomy deferral in patients with endoscopic sphincterotomy. Cochrane Database Syst Rev2007;(4):CD006233.

349. LauJY, LeowCK, FungTM, et al. Cholecystectomy or gallbladder in situ after endoscopic sphincterotomy and bile duct stone removal in Chinese patients. Gastroenterology2006;130:96. CrossRef

350. BoermaD, RauwsEA, KeulemansYC, et al. Wait‐and‐see policy or laparoscopic cholecystectomy after endoscopic sphincterotomy for bile‐duct stones: a randomised trial. Lancet2002;360:761. CrossRef

351. ReindersJS, GoudA, TimmerR, et al. Early laparoscopic cholecystectomy improves outcomes after endoscopic sphincterotomy for choledochocystolithiasis. Gastroenterology2010;138:2315. CrossRef

352. GurusamyK, SahaySJ, BurroughsAK, et al. Systematic review and meta‐analysis of intraoperative versus preoperative endoscopic sphincterotomy in patients with gallbladder and suspected common bile duct stones. Br J Surg2011;98:908. CrossRef

353. BrandM, BizosD, O'FarrellPJr. Antibiotic prophylaxis for patients undergoing elective endoscopic retrograde cholangiopancreatography. Cochrane Database Syst Rev2010;(10):CD007345.

354. RiusM, NiesAT, Hummel‐EisenbeissJ, et al. Cotransport of reduced glutathione with bile salts by MRP4 (ABCC4) localized to the basolateral hepatocyte membrane. Hepatology2003;38:374. CrossRef

355. Alberti‐FlorJJ, IskandaraniM, JeffersL, et al. Mirizzi syndrome. Am J Gastroenterol1985;80:822.

356. LipsettPA, PittHA. Acute cholangitis. Front Biosci2003;8:s1229. CrossRef

357. WadaK, TakadaT, KawaradaY, et al. Diagnostic criteria and severity assessment of acute cholangitis: Tokyo Guidelines. J Hepatobiliary Pancreat Surg2007;14:52. CrossRef

358. KiriyamaS, TakadaT, StrasbergSM, et al. New diagnostic criteria and severity assessment of acute cholangitis in revised Tokyo Guidelines. J Hepatobiliary Pancreat Sci2012;19:548. CrossRef

359. SolomkinJS, MazuskiJE, BaronEJ, et al. Guidelines for the selection of anti‐infective agents for complicated intra‐abdominal infections. Clin Infect Dis2003;37:997. CrossRef

360. PoonRT, LiuCL, LoCM, et al. Management of gallstone cholangitis in the era of laparoscopic cholecystectomy. Arch Surg2001;136:11. CrossRef

361. ForsmarkCE, BaillieJ; AGA Institute Clinical Practice and Economics Committee; AGA Institute Governing Board. AGA Institute technical review on acute pancreatitis. Gastroenterology2007;132:2022. CrossRef

362. SpanierBW, DijkgraafMG, BrunoMJ. Epidemiology, aetiology and outcome of acute and chronic pancreatitis: an update. Best Pract Res Clin Gastroenterol2008;22:45. CrossRef

363. LerchMM, SalujaAK, RunziM, et al. Pancreatic duct obstruction triggers acute necrotizing pancreatitis in the opossum. Gastroenterology1993;104:853.

364. American Gastroenterological Association (AGA) Institute on “Management of Acute Pancreatitis” Clinical Practice and Economics Committee; AGA Institute Governing Board. AGA Institute medical position statement on acute pancreatitis. Gastroenterology2007;132:2019. CrossRef

365. YadavD, AgarwalN, PitchumoniCS. A critical evaluation of laboratory tests in acute pancreatitis. Am J Gastroenterol2002;97:1309. CrossRef

366. WangSS, LinXZ, TsaiYT, et al. Clinical significance of ultrasonography, computed tomography, and biochemical tests in the rapid diagnosis of gallstone‐related pancreatitis: a prospective study. Pancreas1988;3:153. CrossRef

367. NeoptolemosJP, HallAW, FinlayDF, et al. The urgent diagnosis of gallstones in acute pancreatitis: a prospective study of three methods. Br J Surg1984;71:230. CrossRef

368. TennerS, DubnerH, SteinbergW. Predicting gallstone pancreatitis with laboratory parameters: a meta‐analysis. Am J Gastroenterol1994;89:1863.

369. ChangL, LoSK, StabileBE, et al. Gallstone pancreatitis: a prospective study on the incidence of cholangitis and clinical predictors of retained common bile duct stones. Am J Gastroenterol1998;93:527. CrossRef

370. ASGE Standards of Practice Committee; GanSI, RajanE, AdlerDG, et al. Role of EUS. Gastrointest Endosc2007;66:425. CrossRef

371. MesenasS, AngTL, KhorC, et al. Guidelines for endoscopic ultrasonography. Ann Acad Med Singapore2010;39:489.

372. HallalAH, AmorteguiJD, JeroukhimovIM, et al. Magnetic resonance cholangiopancreatography accurately detects common bile duct stones in resolving gallstone pancreatitis. J Am Coll Surg2005;200:869. CrossRef

373. KimYJ, KimMJ, KimKW, et al. Preoperative evaluation of common bile duct stones in patients with gallstone disease. AJR Am J Roentgenol2005;184:1854. CrossRef

374. MoonJH, ChoYD, ChaSW, et al. The detection of bile duct stones in suspected biliary pancreatitis: comparison of MRCP, ERCP, and intraductal US. Am J Gastroenterol2005;100:1051. CrossRef

375. Working Group IAP/APA Acute Pancreatitis Guidelines. IAP/APA evidence‐based guidelines for the management of acute pancreatitis. Pancreatology2013;13:e1. CrossRef

376. HernandezV, PascualI, AlmelaP, et al. Recurrence of acute gallstone pancreatitis and relationship with cholecystectomy or endoscopic sphincterotomy. Am J Gastroenterol2004;99:2417. CrossRef

377. YadavD, O'ConnellM, PapachristouGI. Natural history following the first attack of acute pancreatitis. Am J Gastroenterol2012;107:1096. CrossRef

378. BanksPA, FreemanML, Practice Parameters Committee of the American College of G. Practice guidelines in acute pancreatitis. Am J Gastroenterol2006;101:2379. CrossRef

379. UhlW, MullerCA, KrahenbuhlL, et al. Acute gallstone pancreatitis: timing of laparoscopic cholecystectomy in mild and severe disease. Surg Endosc1999;13:1070. CrossRef

380. KoCW, SekijimaJH, LeeSP. Biliary sludge. Ann Intern Med1999;130:301. CrossRef

381. RosE, NavarroS, BruC, et al. Occult microlithiasis in ‘idiopathic’ acute pancreatitis: prevention of relapses by cholecystectomy or ursodeoxycholic acid therapy [see comments]. Gastroenterology1991;101:1701.

382. AboulianA, ChanT, YaghoubianA, et al. Early cholecystectomy safely decreases hospital stay in patients with mild gallstone pancreatitis: a randomized prospective study. Ann Surg2010;251:615. CrossRef

383. MoraesJM, FelgaGE, ChebliLA, et al. A full solid diet as the initial meal in mild acute pancreatitis is safe and result in a shorter length of hospitalization: results from a prospective, randomized, controlled, double‐blind clinical trial. J Clin Gastroenterol2010;44:517.

384. AfzalS, KristiansenVB, RosenbergJ. [Gallbladder polyps]. Ugeskr Laeger2001;163:5003.

385. LaitioM. Histogenesis of epithelial neoplasms of human gallbladder II. Classification of carcinoma on the basis of morphological features. Pathol Res Pract1983;178:57. CrossRef

386. SalmenkiviK. Cholesterosis of the gall‐bladder. A clinical study based on 269 cholecystectomies. Acta Chir Scand Suppl1964;105(Suppl 324):1.

387. FeldmanM, FeldmanMJr. Cholesterosis of the gallbladder; an autopsy study of 165 cases. Gastroenterology1954;27:641.

388. ChoiJH, YunJW, KimYS, et al. Pre‐operative predictive factors for gallbladder cholesterol polyps using conventional diagnostic imaging. World J Gastroenterol2008;14:6831. CrossRef

389. TerziC, SokmenS, SeckinS, et al. Polypoid lesions of the gallbladder: report of 100 cases with special reference to operative indications. Surgery2000;127:622. CrossRef

390. PatinoJF, QuinteroGA. Asymptomatic cholelithiasis revisited. World J Surg1998;22:1119. CrossRef

391. YangHL, SunYG, WangZ. Polypoid lesions of the gallbladder: diagnosis and indications for surgery. Br J Surg1992;79:227. CrossRef

392. YamaguchiK, ChijiiwaK, IchimiyaH, et al. Gallbladder carcinoma in the era of laparoscopic cholecystectomy. Arch Surg1996;131:981. CrossRef

393. A prospective analysis of 1518 laparoscopic cholecystectomies. The Southern Surgeons Club. N Engl J Med1991;324:1073. CrossRef

394. StromBL, SolowayRD, Rios‐DalenzJL, et al. Risk factors for gallbladder cancer. An international collaborative case‐control study. Cancer1995;76:1747. CrossRef

395. DiehlAK. Epidemiology of gallbladder cancer: a synthesis of recent data. J Natl Cancer Inst1980;65:1209.

396. MisraS, ChaturvediA, MisraNC, et al. Carcinoma of the gallbladder. Lancet Oncol2003;4:167. CrossRef

397. SugiyamaM, AtomiY, YamatoT. Endoscopic ultrasonography for differential diagnosis of polypoid gall bladder lesions: analysis in surgical and follow up series. Gut2000;46:250. CrossRef

398. EdgeSB, ByrdDR, ComptonCC. American Joint Committee on Cancer Staging Manual. New York: Springer; 2010.

399. FongY, WagmanL, GonenM, et al. Evidence‐based gallbladder cancer staging: changing cancer staging by analysis of data from the National Cancer Database. Ann Surg2006;243:767. CrossRef

400. GoetzeTO, PaolucciV. Benefits of reoperation of T2 and more advanced incidental gallbladder carcinoma: analysis of the German registry. Ann Surg2008;247:104. CrossRef

401. OchsnerSF, CarreraGM. Calcification of the gallbladder (“porcelain gallbladder”). Am J Roentgenol Radium Ther Nucl Med1963;89:847.

402. KhanZS, LivingstonEH, HuertaS. Reassessing the need for prophylactic surgery in patients with porcelain gallbladder: case series and systematic review of the literature. Arch Surg2011;146:1143. CrossRef

403. StephenAE, BergerDL. Carcinoma in the porcelain gallbladder: a relationship revisited. Surgery2001;129:699. CrossRef

404. ShodaJ, InadaY, OsugaT. Molecular pathogenesis of hepatolithiasis–a type of low phospholipid‐associated cholelithiasis. Front Biosci2006;11:669. CrossRef

405. JanYY, ChenMF, WangCS, et al. Surgical treatment of hepatolithiasis: long‐term results. Surgery1996;120:509. CrossRef

406. ShapiroMJ, LuchtefeldWB, KurzweilS, et al. Acute acalculous cholecystitis in the critically ill. Am Surg1994;60:335.

407. GofritO, EidA, PikarskyA, et al. Cholesterol embolisation causing chronic acalculous cholecystitis. Eur J Surg1996;162:243.

408. SchwesingerWH, DiehlAK. Changing indications for laparoscopic cholecystectomy. Stones without symptoms and symptoms without stones. Surg Clin North Am1996;76:493. CrossRef

409. WibolttKS, JeffreyRBJr. Acalculous cholecystitis in patients undergoing bone marrow transplantation. Eur J Surg1997;163:519.

410. Romero GanuzaFJ, La BandaG, MontalvoR, et al. Acute acalculous cholecystitis in patients with acute traumatic spinal cord injury. Spinal Cord1997;35:124. CrossRef

411. NashJA, CohenSA. Gallbladder and biliary tract disease in AIDS. Gastroenterol Clin North Am1997;26:323. CrossRef

412. McChesneyJA, NorthupPG, BickstonSJ. Acute acalculous cholecystitis associated with systemic sepsis and visceral arterial hypoperfusion: a case series and review of pathophysiology. Dig Dis Sci2003;48:1960. CrossRef

413. KalliafasS, ZieglerDW, FlancbaumL, et al. Acute acalculous cholecystitis: incidence, risk factors, diagnosis, and outcome. Am Surg1998;64:471.

414. HofmannAF. Primary and secondary prevention of gallstone disease: implications for patient management and research priorities. Am J Surg1993;165:541. CrossRef

415. GrundySM. Cholesterol gallstones: a fellow traveler with metabolic syndrome?Am J Clin Nutr2004;80:1.

416. LeitzmannMF, GiovannucciEL, RimmEB, et al. The relation of physical activity to risk for symptomatic gallstone disease in men. Ann Intern Med1998;128:417. CrossRef

417. WeinsierRL, WilsonLJ, LeeJ. Medically safe rate of weight loss for the treatment of obesity: a guideline based on risk of gallstone formation. Am J Med1995;98:115. CrossRef

418. HeshkaS, SpitzA, NunezC, et al. Obesity and risk of gallstone development on a 1200 kcal/d (5025 Kj/d) regular food diet. Int J Obes Relat Metab Disord1996;20:450.

419. Al‐JiffryBO, ShafferEA, SacconeGT, et al. Changes in gallbladder motility and gallstone formation following laparoscopic gastric banding for morbid obestity. Can J Gastroenterol2003;17:169.

420. LeitzmannMF, WillettWC, RimmEB, et al. A prospective study of coffee consumption and the risk of symptomatic gallstone disease in men. JAMA1999;281:2106. CrossRef

421. LeitzmannMF, StampferMJ, WillettWC, et al. Coffee intake is associated with lower risk of symptomatic gallstone disease in women. Gastroenterology2002;123:1823. CrossRef

422. La VecchiaC, NegriE, D'AvanzoB, et al. Risk factors for gallstone disease requiring surgery. Int J Epidemiol1991;20:209. CrossRef

423. TsaiCJ, LeitzmannMF, WillettWC, et al. Fruit and vegetable consumption and risk of cholecystectomy in women. Am J Med2006;119:760. CrossRef

424. JenkinsSA. Biliary lipids, bile acids and gallstone formation in hypovitaminotic C guinea‐pigs. Br J Nutr1978;40:317. CrossRef

425. SimonJA, HudesES. Serum ascorbic acid and gallbladder disease prevalence among US adults: the Third National Health and Nutrition Examination Survey (NHANES III). Arch Intern Med2000;160:931. CrossRef

426. TsaiCJ, LeitzmannMF, WillettWC, et al. The effect of long‐term intake of cis unsaturated fats on the risk for gallstone disease in men: a prospective cohort study. Ann Intern Med2004;141:514. CrossRef

427. TsaiCJ, LeitzmannMF, HuFB, et al. Frequent nut consumption and decreased risk of cholecystectomy in women. Am J Clin Nutr2004;80:76.

428. LeitzmannMF, TsaiCJ, StampferMJ, et al. Alcohol consumption in relation to risk of cholecystectomy in women. Am J Clin Nutr2003;78:339.

429. PortincasaP, ColecchiaA, Di CiaulaA, et al. Standards for diagnosis of gastrointestinal motility disorders. Ultrasonography. Dig Liver Dis2000;32:160. CrossRef

430. QuigleyEM, MarshMN, ShafferJL, et al. Hepatobiliary complications of total parenteral nutrition. Gastroenterology1993;104:286.

431. MarksJW, SteinT, SchoenfieldLJ. Natural history and treatment with ursodiol of gallstones formed during rapid loss of weight in man. Dig Dis Sci1994;39:1981. CrossRef

432. SitzmannJV, PittHA, SteinbornPA, et al. Cholecystokinin prevents parenteral nutrition induced biliary sludge in humans. Surg Gynecol Obstet1990;170:25.

433. ZoliG, BallingerA, HealyJ, et al. Promotion of gallbladder emptying by intravenous aminoacids. Lancet1993;341:1240. CrossRef

434. SugermanHJ, BrewerWH, ShiffmanML, et al. A multicenter, placebo‐controlled, randomized, double‐blind, prospective trial of prophylactic ursodiol for the prevention of gallstone formation following gastric‐bypass‐induced rapid weight loss. Am J Surg1995;169:91. CrossRef

435. BroomfieldPH, ChopraR, SheinbaumRC, et al. Effects of ursodeoxycholic acid and aspirin on the formation of lithogenic bile and gallstones during loss of weight [see comments]. N Engl J Med1988;319:1567. CrossRef

436. WilliamsC, GowanR, PereyBJ. A double‐blind placebo‐controlled trial of ursodeoxycholic acid in the prevention of gallstones during weight loss after vertical banded gastroplasty. Obes Surg1993;3:257. CrossRef

437. MillerK, HellE, LangB, et al. Gallstone formation prophylaxis after gastric restrictive procedures for weight loss: a randomized double‐blind placebo‐controlled trial. Ann Surg2003;238:697. CrossRef

438. UyMC, Talingdan‐TeMC, EspinosaWZ, et al. Ursodeoxycholic acid in the prevention of gallstone formation after bariatric surgery: a meta‐analysis. Obes Surg2008;18:1532. CrossRef

439. WudelLJJr, WrightJK, DebelakJP, et al. Prevention of gallstone formation in morbidly obese patients undergoing rapid weight loss: results of a randomized controlled pilot study. J Surg Res2002;102:50. CrossRef

440. RotiE, MinelliR, GardiniE, et al. Chronic treatment with a long‐acting somatostatin analogue in a patient with intestinal carcinoid tumor: occurrence of cholelithiasis. J Endocrinol Invest1990;13:69. CrossRef

441. MoschettaA, StolkMF, RehfeldJF, et al. Severe impairment of postprandial cholecystokinin release and gall‐bladder emptying and high risk of gallstone formation in acromegalic patients during Sandostatin LAR. Aliment Pharmacol Ther2001;15:181. CrossRef

442. AvilaNA, ShawkerTH, RoachP, et al. Sonography of gallbladder abnormalities in acromegaly patients following octreotide and ursodiol therapy: incidence and time course. J Clin Ultrasound1998;26:289. CrossRef

443. MontiniM, GianolaD, PaganiMD, et al. Cholelithiasis and acromegaly: therapeutic strategies. Clin Endocrinol (Oxf)1994;40:401. CrossRef

444. TudykaJ, WechslerJG, KratzerW, et al. Gallstone recurrence after successful dissolution therapy. Dig Dis Sci1996;41:235. CrossRef

445. RubinRA, KowalskiTE, KhandelwalM, et al. Ursodiol for hepatobiliary disorders. Ann Intern Med1994;121:207. CrossRef

446. TsumitaR, SugiuraN, AbeA, et al. Long‐term evaluation of extracorporeal shock‐wave lithotripsy for cholesterol gallstones. J Gastroenterol Hepatol2001;16:93. CrossRef

447. GuyattGH, OxmanAD, KunzR, et al. Going from evidence to recommendations. BMJ2008;336:1049. CrossRef

448. GuyattGH, OxmanAD, KunzR, et al. Incorporating considerations of resources use into grading recommendations. BMJ2008;336:1170. CrossRef

449. GuyattGH, OxmanAD, VistGE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ2008;336:924. CrossRef

450. ChalasaniN, YounossiZ, LavineJE, et al. The diagnosis and management of non‐alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Am J Gastroenterol2012;107:811. CrossRef

451. ChalasaniN, YounossiZ, LavineJE, et al. The diagnosis and management of non‐alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology2012;55:2005. CrossRef

452. ChalasaniN, YounossiZ, LavineJE, et al. The diagnosis and management of non‐alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. Gastroenterology2012;142:1592. CrossRef

453. PortincasaP, Di CiaulaA, WangHH, et al. Medicinal treatments of cholesterol gallstones: old, current and new perspectives. Curr Med Chem2009;16:1531. CrossRef

454. PortincasaP, MoschettaA, PuglisiF, et al. Medical treatment of gallstone disease. In: BorzellinoG, CordianoC(eds). Biliary Lithiasis. Basic Science, Current Diagnosis and Management. Milano: Springer Italia S.r.l.; 2008: 149. CrossRef

455. GrunhageF, LammertF. Gallstone disease. Pathogenesis of gallstones: a genetic perspective. Best Pract Res Clin Gastroenterol2006;20:997. CrossRef

456. Infantile cholelithiasis. Pediatr Surg Update2004;23:1.

457. MaurerKR, EverhartJE, EzzatiTM, et al. Prevalence of gallstone disease in Hispanic populations in the United States. Gastroenterology1989;96:487.

458. EversonGT. Pregnancy and gallstones [editorial; comment]. Hepatology1993;17:159. CrossRef

459. KernFJr, EversonGT, DeMarkB, et al. Biliary lipids, bile acids, and gallbladder function in the human female. Effects of pregnancy and the ovulatory cycle. J Clin Invest1981;68:1229. CrossRef

460. KleinS, WaddenT, SugermanHJ. AGA technical review on obesity. Gastroenterology2002;123:882. CrossRef

461. StampferMJ, MaclureKM, ColditzGA, et al. Risk of symptomatic gallstones in women with severe obesity. Am J Clin Nutr1992;55:652.

462. MabeeTM, MeyerP, DenBestenL, et al. The mechanism of increased gallstone formation in obese human subjects. Surgery1976;79:460.

463. FriedmanGD, KannelWB, DawberTR. The epidemiology of gallbladder disease: observations in the Framingham Study. J Chronic Dis1966;19:273. CrossRef

464. VolzkeH, BaumeisterSE, AlteD, et al. Independent risk factors for gallstone formation in a region with high cholelithiasis prevalence. Digestion2005;71:97. CrossRef

465. The epidemiology of gallstone disease in Rome, Italy. Part I. Prevalence data in men. The Rome Group for Epidemiology and Prevention of Cholelithiasis (GREPCO). Hepatology1988;8:904. CrossRef

466. ScraggRK, McMichaelAJ, BaghurstPA. Diet, alcohol, and relative weight in gall stone disease: a case‐control study. Br Med J (Clin Res Ed)1984;288:1113. CrossRef

467. JorgensenT. Prevalence of gallstones in a Danish population. Am J Epidemiol1987;126:912.

468. HaffnerSM, DiehlAK, SternMP, et al. Central adiposity and gallbladder disease in Mexican Americans. Am J Epidemiol1989;129:587.

469. PortincasaP, Di CiaulaA, PalmieriVO, et al. Enhancement of gallbladder emptying in gallstone patients after oral cholestyramine. Am J Gastroenterol1994;89:909.

470. RuhlCE, EverhartJE. Association of diabetes, serum insulin, and C‐peptide with gallbladder disease. Hepatology2000;31:299. CrossRef

471. Al‐AzzawiHH, MathurA, LuD, et al. Resistin‐like molecule alpha reduces gallbladder optimal tension. J Gastrointest Surg2007;11:95. CrossRef

472. ShiffmanML, KaplanGD, Brinkman‐KaplanV, et al. Prophylaxis against gallstone formation with ursodeoxycholic acid in patients participating in a very‐low‐calorie diet program. Ann Intern Med1995;122:899. CrossRef

473. LiVK, PulidoN, FajnwaksP, et al. Predictors of gallstone formation after bariatric surgery: a multivariate analysis of risk factors comparing gastric bypass, gastric banding, and sleeve gastrectomy. Surg Endosc2009;23:1640. CrossRef

474. KamrathRO, PlummerLJ, SadurCN, et al. Cholelithiasis in patients treated with a very‐low‐calorie diet. Am J Clin Nutr1992;56:255S.

475. LiddleRA, GoldsteinRB, SaxtonJ. Gallstone formation during weight‐reduction dieting. Arch Intern Med1989;149:1750. CrossRef

476. ShiffmanML, SugermanHJ, KellumJM, et al. Changes in gallbladder bile composition following gallstone formation and weight reduction. Gastroenterology1992;103:214.

477. TsaiCJ, LeitzmannMF, WillettWC, et al. Weight cycling and risk of gallstone disease in men. Arch Intern Med2006;166:2369. CrossRef

478. SyngalS, CoakleyEH, WillettWC, et al. Long‐term weight patterns and risk for cholecystectomy in women. Ann Intern Med1999;130:471. CrossRef

479. ShiffmanML, SugermanHJ, KellumJM, et al. Gallstone formation after rapid weight loss: a prospective study in patients undergoing gastric bypass surgery for treatment of morbid obesity. Am J Gastroenterol1991;86:1000.

480. LeitzmannMF, RimmEB, WillettWC, et al. Recreational physical activity and the risk of cholecystectomy in women. N Engl J Med1999;341:777. CrossRef

481. BanimPJ, LubenRN, WarehamNJ, et al. Physical activity reduces the risk of symptomatic gallstones: a prospective cohort study. Eur J Gastroenterol Hepatol2010;22:983. CrossRef

482. PhilippE, WilckensT, FriessE, et al. Cholecystokinin, gastrin and stress hormone responses in marathon runners. Peptides1992;13:125. CrossRef

483. TranZV, WeltmanA, GlassGV, et al. The effects of exercise on blood lipids and lipoproteins: a meta‐analysis of studies. Med Sci Sports Exerc1983;15:393.

484. KirwanJP, KohrtWM, WojtaDM, et al. Endurance exercise training reduces glucose‐stimulated insulin levels in 60‐ to 70‐year‐old men and women. J Gerontol1993;48:M84. CrossRef

485. DubracS, ParquetM, BlouquitY, et al. Insulin injections enhance cholesterol gallstone incidence by changing the biliary cholesterol saturation index and apo A‐I concentration in hamsters fed a lithogenic diet. J Hepatol2001;35:550. CrossRef

486. WatkinsJB3rd, CrawfordST, SandersRA. Chronic voluntary exercise may alter hepatobiliary clearance of endogenous and exogenous chemicals in rats. Drug Metab Dispos1994;22:537.

487. PetersHP, De VriesWR, vanBerge‐HenegouwenGP, et al. Potential benefits and hazards of physical activity and exercise on the gastrointestinal tract. Gut2001;48:435. CrossRef

488. TsaiCJ, LeitzmannMF, WillettWC, et al. Long‐term intake of dietary fiber and decreased risk of cholecystectomy in women. Am J Gastroenterol2004;99:1364. CrossRef

489. TsaiCJ, LeitzmannMF, HuFB, et al. A prospective cohort study of nut consumption and the risk of gallstone disease in men. Am J Epidemiol2004;160:961. CrossRef

490. TsaiCJ, LeitzmannMF, WillettWC, et al. Dietary carbohydrates and glycaemic load and the incidence of symptomatic gall stone disease in men. Gut2005;54:823. CrossRef

491. TsaiCJ, LeitzmannMF, WillettWC, et al. Central adiposity, regional fat distribution, and the risk of cholecystectomy in women. Gut2006;55:708. CrossRef

492. TsunodaK, ShiraiY, HatakeyamaK. Prevalence of cholesterol gallstones positively correlates with per capita daily calorie intake. Hepatogastroenterology2004;51:1271.

493. MisciagnaG, CentonzeS, LeociC, et al. Diet, physical activity, and gallstones–a population‐based, case‐ control study in southern Italy. Am J Clin Nutr1999;69:120.

494. AttiliAF, ScafatoE, MarchioliR, et al. Diet and gallstones in Italy: the cross‐sectional MICOL results. Hepatology1998;27:1492. CrossRef

495. MaclureKM, HayesKC, ColditzGA, et al. Weight, diet, and the risk of symptomatic gallstones in middle‐aged women. N Engl J Med1989;321:563. CrossRef

496. SichieriR, EverhartJE, RothH. A prospective study of hospitalization with gallstone disease among women: role of dietary factors, fasting period, and dieting. Am J Public Health1991;81:880. CrossRef

497. HeatonKW, EmmettPM, SymesCL, et al. An explanation for gallstones in normal‐weight woman: slow intestinal transit. Lancet1993;341:8. CrossRef

498. StokesCS, KrawczykM, LammertF. Gallstones: environment, lifestyle and genes. Dig Dis2011;29:191. CrossRef

499. SchwesingerWH, KurtinWE, PageCP, et al. Soluble dietary fiber protects against cholesterol gallstone formation. Am J Surg1999;177:307. CrossRef

500. TsaiCJ, LeitzmannMF, WillettWC, et al. Long‐term intake of trans‐fatty acids and risk of gallstone disease in men. Arch Intern Med2005;165:1011. CrossRef

501. TsaiCJ, LeitzmannMF, WillettWC, et al. Long‐chain saturated fatty acids consumption and risk of gallstone disease among men. Ann Surg2008;247:95. CrossRef

502. AbeteI, AstrupA, MartinezJA, et al. Obesity and the metabolic syndrome: role of different dietary macronutrient distribution patterns and specific nutritional components on weight loss and maintenance. Nutr Rev2010;68:214. CrossRef

503. LiuB, BalkwillA, RoddamA, et al. Separate and joint effects of alcohol and smoking on the risks of cirrhosis and gallbladder disease in middle‐aged women. Am J Epidemiol2009;169:153. CrossRef

504. SmeltAH. Triglycerides and gallstone formation. Clin Chim Acta2010;411:1625. CrossRef

505. AttiliAF, CapocacciaR, CarulliN, et al. Factors associated with gallstone disease in the MICOL experience. Multicenter Italian Study on Epidemiology of Cholelithiasis. Hepatology1997;26:809. CrossRef

506. ThijsC, KnipschildP, BrombacherP. Serum lipids and gallstones: a case‐control study. Gastroenterology1990;99:843.

507. HalldestamI, KullmanE, BorchK. Incidence of and potential risk factors for gallstone disease in a general population sample. Br J Surg2009;96:1315. CrossRef

508. ScraggRK, CalvertGD, OliverJR. Plasma lipids and insulin in gall stone disease: a case‐control study. Br Med J (Clin Res Ed)1984;289:521. CrossRef

509. MarksJW, ClearyPA, AlbersJJ. Lack of correlation between serum lipoproteins and biliary cholesterol saturation in patients with gallstones. Dig Dis Sci1984;29:1118. CrossRef

510. Van ErpecumKJ. Pathogenesis of cholesterol and pigment gallstones: an update. Clin Res Hepatol Gastroenterol2011;35:281. CrossRef

511. LammertF, MiquelJF. Gallstone disease: from genes to evidence‐based therapy. J Hepatol2008;48(Suppl 1):S124. CrossRef

512. PortincasaP, MoschettaA, BerardinoM, et al. Impaired gallbladder motility and delayed orocecal transit contribute to pigment gallstone and biliary sludge formation in beta‐thalassemia major adults. World J Gastroenterol2004;10:2383. CrossRef

513. ConteVP. Normal neuronal features of the human gallbladder and structural changes in cholelithiasis patients. Rev Hosp Clin Fac Med Sao Paulo1989;44:211.

514. FornariF, ImbertiD, SquillanteMM, et al. Incidence of gallstones in a population of patients with cirrhosis. J Hepatol1994;20:797. CrossRef

515. PoynardT, LonjonI, MathurinP, et al. Prevalence of cholelithiasis according to alcoholic liver disease: a possible role of apolipoproteins AI and AII. Alcohol Clin Exp Res1995;19:75. CrossRef

516. VitekL, CareyMC. Enterohepatic cycling of bilirubin as a cause of ‘black’ pigment gallstones in adult life. Eur J Clin Invest2003;33:799. CrossRef

517. AlvaroD, AngelicoM, GandinC, et al. Physico‐chemical factors predisposing to pigment gallstone formation in liver cirrhosis. J Hepatol1990;10:228. CrossRef

518. AcalovschiM, DumitrascuDL, CsakanyI. Gastric and gall bladder emptying of a mixed meal are not coordinated in liver cirrhosis – a simultaneous sonographic study. Gut1997;40:412. CrossRef

519. ConteD, FraquelliM, FornariF, et al. Close relation between cirrhosis and gallstones: cross‐sectional and longitudinal survey. Arch Intern Med1999;159:49. CrossRef

520. StauberRE, RosenblumE, EagonPK, et al. The effect of portal‐systemic shunting on hepatic sex hormone receptors in male rats. Gastroenterology1991;100:168.

521. WalcherT, HaenleMM, MasonRA, et al. The effect of alcohol, tobacco and caffeine consumption and vegetarian diet on gallstone prevalence. Eur J Gastroenterol Hepatol2010;22:1345. CrossRef

522. ApsteinMD, Dalecki‐ChipperfieldK. Spinal cord injury is a risk factor for gallstone disease. Gastroenterology1987;92:966.

523. BaltasCS, BalanikaAP, SgantzosMN, et al. Gallstones and biliary sludge in Greek patients with complete high spinal cord injury: an ultrasonographical evaluation. Singapore Med J2009;50:889.

524. MoonkaR, StiensSA, ResnickWJ, et al. The prevalence and natural history of gallstones in spinal cord injured patients. J Am Coll Surg1999;189:274. CrossRef

525. StolkMF, van ErpecumKJ, HiemstraG, et al. Gallbladder motility and cholecystokinin release during long‐ term enteral nutrition in patients with Crohn's disease. Scand J Gastroenterol1994;29:934. CrossRef

526. NightingaleJM, Lennard JonesJE, GertnerDJ, et al. Colonic preservation reduces need for parenteral therapy, increases incidence of renal stones, but does not change high prevalence of gall stones in patients with a short bowel. Gut1992;33:1493. CrossRef

527. HussainiSH, MaghsoudlooM, MurphyGM, et al. Octreotide (OT) increases the proportion of deoxycholic acid in gallbladder (GB) bile‐ the prime mover in the pathogenesis of octreotide‐induced gallbladder stones (GBS)?Gut1992;33:57S.

528. HussainiSH, MurphyGM, PetitR, et al. The role of bile composition and physical chemistry in the pathogenesis of octreotide‐associated gallbladder stones. Gastroenterology1994;107:1503. CrossRef

529. EzzatS, SnyderPJ, YoungWF, et al. Octreotide treatment of acromegaly. A randomized, multicenter study. Ann Intern Med1992;117:711. CrossRef

530. NewmanCB, MelmedS, SnyderPJ, et al. Safety and efficacy of long‐term octreotide therapy of acromegaly: results of a multicenter trial in 103 patients–a clinical research center study. J Clin Endocrinol Metab1995;80:2768.

531. HussainiSH, PereiraSP, DowlingRH, et al. Slow intestinal transit and gallstone formation [letter]. Lancet1993;341:638. CrossRef

532. KodamaI, YoshidaC, KofujiK, et al. Gallstones and gallbladder disorder after gastrectomy for gastric cancer. Int Surg1996;81:36.

533. FukagawaT, KataiH, SakaM, et al. Gallstone formation after gastric cancer surgery. J Gastrointest Surg2009;13:886. CrossRef

534. Di CiaulaA, WangDQ, PortincasaP. Gallbladder and gastric motility in obese newborns, pre‐adolescents and adults. J Gastroenterol Hepatol2012;27:1298. CrossRef

535. PalascianoG, PortincasaP, BelfioreA, et al. Gallbladder volume and emptying in diabetics: the role of neuropathy and obesity. J Intern Med1992;231:123. CrossRef

536. PortincasaP, Di CiaulaA, PalmieriVO, et al. Ultrasonographic study of gallbladder (GB) and gastric postprandial emptying in obese and lean subjects: effect of cholestyramine (CS) alone or combined with erythromycin (EM). Neth J Med1994;45:A35.

537. Di CiaulaA, CovelliM, BerardinoM, et al. Gastrointestinal symptoms and motility disorders in patients with systemic scleroderma. BMC Gastroenterol2008;8:7. CrossRef

538. PortincasaP, MoschettaA, Di CiaulaA, et al. Changes of gallbladder and gastric dynamics in patients with acute hepatitis A. Eur J Clin Invest2001;31:617. CrossRef

539. ParenteF, PastoreL, BargiggiaS, et al. Incidence and risk factors for gallstones in patients with inflammatory bowel disease: a large case‐control study. Hepatology2007;45:1267. CrossRef

540. FraquelliM, LoscoA, VisentinS, et al. Gallstone disease and related risk factors in patients with Crohn disease: analysis of 330 consecutive cases. Arch Intern Med2001;161:2201. CrossRef

541. GrodsteinF, ColditzGA, StampferMJ. Postmenopausal hormone use and cholecystectomy in a large prospective study. Obstet Gynecol1994;83:5.

542. HenrikssonP, EinarssonK, ErikssonA, et al. Estrogen‐induced gallstone formation in males. Relation to changes in serum and biliary lipids during hormonal treatment of prostatic carcinoma. J Clin Invest1989;84:811. CrossRef

543. HonoreLH. Increased incidence of symptomatic cholesterol cholelithiasis in perimenopausal women receiving estrogen replacement therapy: a retrospective study. J Reprod Med1980;25:187.

544. Gallbladder disease as a side effect of drugs influencing lipid metabolism. Experience in the Coronary Drug Project. N Engl J Med1977;296:1185. CrossRef

545. ThijsC, KnipschildP. Oral contraceptives and the risk of gallbladder disease: a meta‐analysis. Am J Public Health1993;83:1113. CrossRef

546. ThijsC, LeffersP, KnipschildP. Oral contraceptive use and the occurrence of gallstone disease–a case‐control study. Prev Med1993;22:122. CrossRef

547. StromBL, TamragouriRN, MorseML, et al. Oral contraceptives and other risk factors for gallbladder disease. Clin Pharmacol Ther1986;39:335. CrossRef

548. ScraggRK, McMichaelAJ, SeamarkRF. Oral contraceptives, pregnancy, and endogenous oestrogen in gall stone disease–a case‐control study. Br Med J (Clin Res Ed)1984;288:1795. CrossRef

549. PortincasaP, MoschettaA, Di CiaulaA, et al. Pathophysiology of cholesterol gallstone disease. In: BorzellinoG, CordianoC(eds). Biliary Lithiasis. Basic Science, Current Diagnosis and Management. Milano: Springer Italia S.r.l.; 2008: 19. CrossRef

550. WangHH, LiuM, CleggDJ, et al. New insights into the molecular mechanisms underlying effects of estrogen on cholesterol gallstone formation. Biochim Biophys Acta2009;1791:1037. CrossRef

551. RanellettiFO, PiantelliM, FarinonAM, et al. Estrogen and progesterone receptors in the gallbladders from patients with gallstones. Hepatology1991;14:608.

552. ShiffmanML, KeithFB, MooreEW. Pathogenesis of ceftriaxone‐associated biliary sludge. In vitro studies of calcium‐ceftriaxone binding and solubility. Gastroenterology1990;99:1772.

553. StahlbergD, ReihnerE, RudlingM, et al. Influence of bezafibrate on hepatic cholesterol metabolism in gallstone patients: reduced activity of cholesterol 7 alpha‐hydroxylase. Hepatology1995;21:1025.

554. McDonaldGB. Review article: management of hepatic disease following haematopoietic cell transplant. Aliment Pharmacol Ther2006;24:441. CrossRef

555. StiefJ, StempfleHU, GotzbergerM, et al. Biliary diseases in heart transplanted patients: a comparison between cyclosporine A versus tacrolimus‐based immunosuppression. Eur J Med Res2009;14:206. CrossRef

556. LeitzmannMF, TsaiCJ, StampferMJ, et al. Thiazide diuretics and the risk of gallbladder disease requiring surgery in women. Arch Intern Med2005;165:567. CrossRef

557. ChapmanBA, WilsonIR, FramptonCM, et al. Prevalence of gallbladder disease in diabetes mellitus. Dig Dis Sci1996;41:2222. CrossRef

558. De SantisA, AttiliAF, Ginanni CorradiniS, et al. Gallstones and diabetes: a case‐control study in a free‐living population sample. Hepatology1997;25:787. CrossRef

559. HahmJS, ParkJY, ParkKG, et al. Gallbladder motility in diabetes mellitus using real time ultrasonography. Am J Gastroenterol1996;91:2391.

560. Mendez‐SanchezN, Chavez‐TapiaNC, Zamora‐ValdesD, et al. Hepatobiliary diseases and insulin resistance. Curr Med Chem2007;14:1988. CrossRef

561. NakeebA, ComuzzieAG, Al AzzawiH, et al. Insulin resistance causes human gallbladder dysmotility. J Gastrointest Surg2006;10:940. CrossRef

562. TranKQ, GoldblattMI, Swartz‐BasileDA, et al. Diabetes and hyperlipidemia correlate with gallbladder contractility in leptin‐related murine obesity. J Gastrointest Surg2003;7:857. CrossRef

563. LapidusA, EinarssonK. Effects of ileal resection on biliary lipids and bile acid composition in patients with Crohn's disease. Gut1991;32:1488. CrossRef

564. BrinkMA, SlorsJF, KeulemansYC, et al. Enterohepatic cycling of bilirubin: a putative mechanism for pigment gallstone formation in ileal Crohn's disease. Gastroenterology1999;116:1420. CrossRef

565. ShafferEA. Gallstone disease: epidemiology of gallbladder stone disease. Best Pract Res Clin Gastroenterol2006;20:981. CrossRef

566. MaurerKJ, CareyMC, FoxJG. Roles of infection, inflammation, and the immune system in cholesterol gallstone formation. Gastroenterology2009;136:425. CrossRef

567. AcalovschiM, BuzasC, RaduC, et al. Hepatitis C virus infection is a risk factor for gallstone disease: a prospective hospital‐based study of patients with chronic viral C hepatitis. J Viral Hepat2009;16:860. CrossRef

568. StroffoliniT, SagnelliE, MeleA, et al. HCV infection is a risk factor for gallstone disease in liver cirrhosis: an Italian epidemiological survey. J Viral Hepat2007;14:618. CrossRef

569. BiniEJ, McGreadyJ. Prevalence of gallbladder disease among persons with hepatitis C virus infection in the United States. Hepatology2005;41:1029. CrossRef

570. EguchiY, MizutaT, IshibashiE, et al. Hepatitis C virus infection enhances insulin resistance induced by visceral fat accumulation. Liver Int2009;29:213. CrossRef

571. DuerksenDR, FallowsG, BernsteinCN. Vitamin B12 malabsorption in patients with limited ileal resection. Nutrition2006;22:1210. CrossRef

572. TsaiCJ, LeitzmannMF, WillettWC, et al. Long‐term effect of magnesium consumption on the risk of symptomatic gallstone disease among men. Am J Gastroenterol2008;103:375. CrossRef

573. KoCW. Magnesium: does a mineral prevent gallstones?Am J Gastroenterol2008;103:383. CrossRef

574. EvangelopoulosAA, VallianouNG, PanagiotakosDB, et al. An inverse relationship between cumulating components of the metabolic syndrome and serum magnesium levels. Nutr Res2008;28:659. CrossRef

575. DiehlAK, SugarekNJ, ToddKH. Clinical evaluation for gallstone disease: usefulness of symptoms and signs in diagnosis. Am J Med1990;89:29. CrossRef

576. RigasB, TorosisJ, McDougallCJ, et al. The circadian rhythm of biliary colic. J Clin Gastroenterol1990;12:409. CrossRef

577. MinoliG, ImperialeG, SpinziGC, et al. Circadian periodicity and other clinical features of biliary pain. J Clin Gastroenterol1991;13:546. CrossRef

578. FestiD, SottiliS, ColecchiaA, et al. Clinical manifestations of gallstone disease: evidence from the multicenter Italian study on cholelithiasis (MICOL). Hepatology1999;30:839. CrossRef

579. LundJ. Surgical indications in cholelithiasis: prophylactic choleithiasis: prophylactic cholecystectomy elucidated on the basis of long‐term follow up on 526 nonoperated cases. Ann Surg1960;151:153. CrossRef

580. BerhaneT, VetrhusM, HauskenT, et al. Pain attacks in non‐complicated and complicated gallstone disease have a characteristic pattern and are accompanied by dyspepsia in most patients: the results of a prospective study. Scand J Gastroenterol2006;41:93. CrossRef

581. SungJY, CostertonJW, ShafferEA. Defense system in the biliary tract against bacterial infection. Dig Dis Sci1992;37:689. CrossRef

582. SaikRP, GreenburgAG, FarrisJM, et al. Spectrum of cholangitis. Am J Surg1975;130:143. CrossRef

583. LeeMG, LeeHJ, KimMH, et al. Extrahepatic biliary diseases: 3D MR cholangiopancreatography compared with endoscopic retrograde cholangiopancreatography. Radiology1997;202:663. CrossRef

584. ChanYL, ChanAC, LamWW, et al. Choledocholithiasis: comparison of MR cholangiography and endoscopic retrograde cholangiography. Radiology1996;200:85. CrossRef

585. TackJ, TalleyNJ, CamilleriM, et al. Functional gastroduodenal disorders. Gastroenterology2006;130:1466. CrossRef

586. FlanaginBA, MitchellMT, ThistlethwaiteWA, et al. Diagnosis and treatment of atypical presentations of hiatal hernia following bariatric surgery. Obes Surg2010;20:386. CrossRef

587. SelzerM, SpencerWA. Interactions between visceral and cutaneous afferents in the spinal cord: reciprocal primary afferent fiber depolarization. Brain Res1969;14:349. CrossRef

588. VillegasL, SchneiderB, ProvostD, et al. Is routine cholecystectomy required during laparoscopic gastric bypass?Obes Surg2004;14:206. CrossRef

589. HamadGG, IkramuddinS, GourashWF, et al. Elective cholecystectomy during laparoscopic Roux‐en‐Y gastric bypass: is it worth the wait?Obes Surg2003;13:76. CrossRef

590. OkamotoM, OkamotoH, KitaharaF, et al. Ultrasonographic evidence of association of polyps and stones with gallbladder cancer. Am J Gastroenterol1999;94:446. CrossRef

591. BerkRN, ArmbusterTG, SaltzsteinSL. Carcinoma in the porcelain gallbladder. Radiology1973;106:29. CrossRef

592. DuttaU, GargPK, KumarR, et al. Typhoid carriers among patients with gallstones are at increased risk for carcinoma of the gallbladder. Am J Gastroenterol2000;95:784. CrossRef

593. DiehlAK. Gallstone size and the risk of gallbladder cancer. JAMA1983;250:2323. CrossRef

594. WattchowDA, HallJC, WhitingMJ, et al. Prevalence and treatment of gall stones after gastric bypass surgery for morbid obesity. Br Med J (Clin Res Ed)1983;286:763. CrossRef